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Summary 
In this thesis I documented the development of an artificial nerve conduit and subsequent 
biological testing within an animal model of peripheral nerve injury. The focus for the 
development of the conduit lied in the utilization of electrospun microfibers to serve as a guidance 
structure for Schwann cells and axons during regeneration. Through the incorporation of such a 
guidance structure into the lumen of a conventional hollow nerve conduit, Schwann cell migration 
and axonal elongation across artificial nerve conduits was supposed to be facilitated, thereby 
expanding the applicability of artificial nerve conduits to the repair of larger nerve gaps. 
To achieve this I initially established a procedure to produce three-dimensional arrays of aligned 
microfibers. Through embedding of these arrays into a biocompatible hydrogel I created a 
scaffold with an integrated guidance structure, which can be incorporated into a conventional 
nerve conduit. This scaffold was then used to confirm in vitro, whether the guidance properties, 
the fibers exerted under two-dimensional conditions, are preserved in a three dimensional 
environment. Since the hydrogel (e.g. collagen) could potentially compete with the fibers for the 
interaction with cells due to its fibrillary structure. 
Subsequently the new implants were assembled through incorporation of the scaffold into 
conventional conduits and the benefit of the integrated structure was then evaluated in comparison 
to the autologous nerve graft and the conventional hollow conduit by using an animal model of 
peripheral nerve injury. For this, a sciatic nerve lesion was performed in rats (Rattus norvegicus), 
which was subsequently repaired by insertion of the respective im-/transplant. Assessment of 
recovery by means of immunohistological investigation of the regenerated nerve, 
electromyography, determination of muscle weight as well as different behavioral tests, revealed 
an advantage of the internally structured conduit over the conventional hollow conduit, 
particularly when the integrated fibers contained proteins derived from the extracellular matrix. 
Thus, even though the autologous nerve graft still performed considerably better than the other 
implants tested, the new structured design offers several possibilities for further optimization and 
thus presents a promising approach to narrow the gap between autologous nerve grafts and their 
artificial alternatives. 
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Zusammenfassung 
In der vorliegenden Dissertation ist die Entwicklung eines künstlichen Nervenimplantats bis hin 
zur Überprüfung der Wirksamkeit innerhalb eines Tierversuchs dokumentiert. Der Schwerpunkt 
bei der Entwicklung des künstlichen Nervenimplantats lag in der Verwendung von Mikrofasern 
als Leitstruktur für Schwannzellen und Axone während der Regeneration. Durch Integration 
dieser Leitstruktur in das Lumen eines konventionellen Nervenconduits sollte die Wegfindung 
besagter Zellen über das Conduit verbessert, und die Anwendung künstlicher Implantate zur 
Überbrückung größerer Läsionen ermöglicht werden. 
Um dies zu erreichen, wurde zunächst ein Verfahren zur Erzeugung parallel ausgerichteter 
Mikrofasern in dreidimensionaler Anordnung entwickelt. Durch Einbetten der Fasern in ein 
Hydrogel wurde eine Matrix mit integrierten Leitstrukturen erzeugt, die in ein konventionelles 
Conduit integriert werden kann. Mit dieser Matrix wurde zunächst in einem in vitro Experiment 
überprüft, ob die Fähigkeit der Fasern, die Wuchsrichtung von Zellen vorzugeben, auch in einer 
dreidimensionalen Umgebung erhalten bleibt. Da diese aufgrund ihrer Struktur potentiell mit den 
Fasern um die Interaktion mit den Zellen konkurrieren könnte. 
Anschließend wurde die Wirksamkeit des neu entworfenen Implantats im Vergleich zum 
autologen Transplantat und einem konventionellen Conduit, in einem Tierversuch überprüft. 
Hierzu wurde eine Läsion des Nervus ischiadicus in der Ratte (Rattus norvegicus) gesetzt, durch 
das entsprechende Im-/Transplantat überbrückt, und der regenerative Erfolg über einen Zeitraum 
von zwölf Wochen mittels immunhistologischer Färbung der Nervenregenerate, 
Elektromyographie, Bestimmung des Muskelgewichts der betroffenen Gliedmaßen und 
verschiedener Verhaltensexperimente bewertet. Dabei zeigte sich eine Überlegenheit des von uns 
entworfenen Implantats gegenüber dem konventionellen Implantat, insbesondere bei 
Anreicherung der Fasern mit Proteinen der extrazellulären Matrix. Allerdings war die 
Überlegenheit des autologen Transplantats gegenüber künstlichen Implantaten auch in unseren 
Experimenten augenscheinlich. Nichtsdestotrotz scheint der hier vorgestellte Ansatz, bezüglich 
der Struktur künstlicher Implantate, angesichts zahlreicher Möglichkeiten zur weiteren 
Optimierung, geeignet den Abstand zwischen autologem Transplantat und künstlichen 
Implantaten zu verringern. 
The peripheral nervous system 
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General Introduction 
In general, peripheral nerve injuries (PNI) are not very frequent. Different studies and statistical 
surveys show an incidence of approximately two percent for injuries to the extremities (Robinson, 
2004; Taylor et al., 2008) accompanied by a prevalence of around three percent (Noble et al., 
1998). Nevertheless, their socio-economic implications should not be underestimated. 
First of all, there is thought to be a relatively high number of cases were the diagnosis of the 
actual PNI is delayed, because shortly after an accident the treatment of the apparent injuries is 
usually in the focus. Thus a considerable number of cases might fail to enter the statistics 
correctly. Furthermore data from the Swiss accident analysis and statistics from 1997 (UVG) 
show that the duration of working inability caused by injuries to nerves and the spinal cord is 
nearly twice as long as compared to injuries in general (26,8 days vs 14,7 days). Additionally PNI 
are mostly affecting the upper extremities. Thus the functional impairment in particular of the 
hands can notably reduce the patient’s professional capacity for a long time and over a wide range 
of working fields. This is displayed by the high follow-up costs of such injuries. For injuries to 
the median and ulnar nerve, lost production makes up 87 percent of the total costs and 67 percent 
for injuries to the hand and forearm in general (Rosberg et al., 2005). On top of that, the patients 
suffering from PNI are relatively young with most patients between 20 and 40 years of age (Noble 
et al., 1998; Eser et al., 2009; Ciaramitaro et al., 2010). For this group of people, the functional 
impairment and the accompanying loss of personal independence, together with the high risk of 
enduring neuropathic pain, strongly diminishes the perceived quality of life. 
To explain why the treatment of these injuries presents such a challenge to the physicians in 
charge, I will briefly described the causes, consequences and possible therapies of PNI in the 
following. 
The peripheral nervous system 
The peripheral nervous system (PNS) comprises all nerves and ganglia not located within the 
brain or the spinal cord, i.e. the cranial nerves (except of the optic nerve) and the spinal nerves. 
The main function of the PNS is the relay of sensory information from the periphery to the central 
nervous system (CNS) and the propagation of information from the CNS to the musculature and 
other organs in the periphery. It can be divided into the somatic nervous system enabling 
voluntary control of skeletal musculature and the autonomic nervous system mainly involuntarily 
influencing internal organs and related body functions. Thus a peripheral nerve (PN) can, 
depending on the innervated target organ, consist of a composition of afferent sensory axons and 
efferent motor or effector axons, which according to the individual fiber type, are more or less 
enwrapped by the cell membrane of Schwann cells, the myelinating glia cell of the PNS. The 
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single axons are surrounded by the endoneurium, a connective tissue forming an endoneurial tube 
along the complete length of the axon. Multiple axons are ensheathed by a lamellar arrangement 
of perineurial cells (the perineurium) forming a fascicle. Several of these fascicles, together with 
blood vessels, are embedded in connective tissue, called epineurium, to form a complete PN. 
Injuries to the peripheral nervous system 
The PNS is the essential relay station for the interaction of vertebrates with their environment and 
the regulation of their homeostasis. However, unlike the central parts of the nervous system, i.e. 
brain and spinal cord, which are surrounded by the cranium and the vertebrate column, the PNS is 
not protected by bone tissue. Thus nerves of the PNS are particularly susceptible to traumatic 
injuries, especially if located in the extremities. The main cause for these injuries are traffic 
accidents, followed by gunshot and cutting wounds, and are primarily affecting the upper 
extremities as confirmed by an international survey in 49 countries (Scholz et al., 2009). The 
consequence of a PNI is a loss of function of the innervated organ or muscle. The extent and 
duration of this loss of function is essentially dependent on the position and severity of the trauma 
and also on the applicable therapy. 
The mildest form of PNI is a neuropraxia according to Seddon (Seddon, 1943) or a grade one 
injury according to Sunderland (Sunderland, 1951). It can be caused for example by a nerve 
compression that results in a damage of the myelin sheath and thus impairs signal conduction. 
Since the nerve fibers as such stay intact, there usually is a rapid recovery of function after nerve 
conduction is restored. 
If the axon itself is damaged, but the surrounding connective tissue stays intact, one talks about 
axonotmesis (Seddon, 1943) or Sunderland grade two. In this case degenerative processes will be 
initiated, which for example lead to a break down and degradation of myelin and axonal parts 
distal to the injury. This is followed by axonal regeneration from the proximal stump towards the 
original site of innervation. The speed of functional recovery after axonotmesis is obviously 
limited by the growth rate of the regenerating axons and thus does strongly depend on the distance 
between site of injury and the target organ. However, as the still intact endoneurial tube serves as 
a guidance structure for the regrowing axons, the prospects for functional recovery are relatively 
high. 
The most severe case of a PNI is called neurotmesis according to Seddon, which is further divided 
by Sunderland in grades three to five and ranges from transection of the axon and its endoneurial 
tube up to a complete transection of the nerve. In the milder cases of neurotmesis, where damage 
to connective tissue structures is limited, regeneration is possible without surgical intervention, 
but there is increasing probability of aberrant sprouting and neuroma formation. In the case of a 
Peripheral nerve repair 
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complete nerve transection, however, surgical intervention is obligatory to preserve a chance for 
functional recovery. 
Peripheral nerve repair 
A complete nerve transection results in a gap between the two nerve stumps. They have to be 
reconnected by a surgical intervention to enable regeneration. If the resultant gap is small (less 
than a few mm), e.g. after a clean cut, it can be sufficient to bring both stumps together and secure 
them by end to end neurorrhaphy. However, frequently the amount of tissue damage or delayed 
repair, which generates the necessity for trimming the nerve stumps to get a plane surface, leads 
to nerve gaps considerable bigger than that. In this case continuity must not be restored by a 
neurorrhaphy, since this would apply strain on the nerve, having detrimental effects for 
regeneration. Thus, if relocation of the nerve to avoid strain is not possible, the insertion of a 
nerve bridge is necessary (005/010 S3-Leitlinie, 2013). For this purpose, several biological 
materials, e.g. muscle or vein grafts, are conceivable and their applicability is experimentally 
investigated (Meek et al., 2004; Nijhuis et al., 2013). Despite this, the standard procedure is the 
insertion of an autologous nerve graft, which usually is a piece of sensory nerve, most frequently 
the N. suralis, N. saphenus, N. cutaneus antebrachii medialis or lateralis (005/010 S3-Leitlinie, 
2013). This has, by far, the best prediction for a recovery of function, but comes along with major 
drawbacks. These are, a limited availability of donor material, which more or less applies to most 
biological materials, and a loss of function at the donor site, which is a particular problem of 
autologous nerve grafts. To overcome these constrictions, there has been continuous research in 
the past decades to test and evaluate different artificial materials in their ability to substitute the 
established autologous nerve graft. It has led to the availability of clinically approved artificial 
nerve conduits of different biodegradable, non-toxic materials that hardly exhibit complications, 
e.g. encapsulation or increased inflammatory reactions (Meek and Coert, 2008a). However, while 
these nerve conduits show satisfactory results when used to bridge small nerve gaps, the predicted 
functional recovery dramatically decreases with increasing gap size, compared to the autologous 
nerve graft. Therefore 30 mm are usually considered as the maximum gap size to be bridged via 
tubulization with artificial nerve conduits (Meek and Coert, 2012, 2014). Generally this is 
attributed to a lack of guidance cues and trophic support. An autologous nerve graft offers 
thousands of endoneurial tubes that regrowing axons can follow to reach the distal stump, while 
being supported by growth factors released from Schwann cells inside the graft. Compared to that 
directional support in the conventional artificial nerve conduit is very poor, as they consist of 
hollow tubes with a saline filling. For this reason, a main focus of current research regarding 
peripheral nerve repair is the implementation of structural guidance cues into artificial nerve 
conduits. 
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Aim and structure of the thesis 
The goal of the project was to develop and test a cell-free artificial nerve conduit for peripheral 
nerve repair that made use of electrospun, sub-micron scale fibers to improve axonal guidance. In 
chapter I of the thesis I reviewed the theoretical background regarding biological processes 
involved in peripheral nerve injury and regeneration as well as the current state of research in 
peripheral nerve repair. Particular emphasis was put on design strategies for the improvement of 
axonal guidance, the choice of materials (biological and non-biological) for artificial nerve 
conduits and the incorporation of biological signaling molecules. 
To achieve the experimental goal of an artificial nerve conduit the following milestones were to 
be reached: 
1. Designing an electrospinning device that allowed producing three-dimensional (3D) 
arrays of parallel fibers for axonal guidance. This included the characterization of fiber 
properties associated with their applicability for peripheral nerve repair, e.g. fiber 
diameter, density and degree of alignment. 
2. Manufacturing a 3D scaffold which incorporated the guidance fibers. This included, 
finding a biocompatible hydrogel with suitable physical properties and establishing a 
procedure for the embedding of the fiber arrays in the gel. 
3. Verification of the biological properties, specifically with respect to axonal guidance and 
cell migration, of the 3D fiber/gel construct. Guidance properties of the fibers used had 
been shown on 2D substrates in previous studies, but needed to be confirmed for the 3D 
scaffolds with appropriate cell types in vitro. 
4. Integration of the 3D scaffold into an implantable tube to be tested in vivo. This device 
was intended to allow for long-term storage and should be quickly available if needed. 
5. Biological testing of the conduit: the efficacy to support peripheral nerve regeneration 
was to be tested in vivo using the sciatic nerve lesion model in rats. Regenerative success 
was to be evaluated: 
a. On functional level with behavioral experiments, i.e. toe spread analysis and grip 
strength test 
b. On physiological level with electromygraphical recordings from the foot 
musculature after stimulation of the nerve 
c. By preparation of immunohistological stainings of the regenerated nerve tissue 
and determination of muscle weights in the affected limb. 
The experiments associated with the above mentioned milestones one to three are presented in 
chapter II of this thesis, while the respective experiments for milestones four and five are 
presented in chapter III. 
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Chapter I 
Theoretical background on peripheral nerve repair and design 
strategies for artificial implants 
1 Introduction 
Peripheral nerves transmit motor, sensory and autonomic information between the central nervous 
system (CNS) and the rest of the body. If a peripheral nerve is severed, e.g., by an injury to the 
face or limbs, these functions are lost. However, in contrast to the mostly non-regenerative 
processes after spinal cord lesions, axons in the peripheral nervous system (PNS) are able to 
regenerate, and the long-term functional outcome of peripheral nerve injury depends on the 
severity of the trauma (Sunderland, 1951). The cell somata of PNS neurons are localized in the 
ventral horn of the spinal cord (motor neurons), the dorsal root ganglia (DRG; sensory neurons), 
or in the sympathetic chain ganglia close to the spinal column (neurons of the autonomic nervous 
system). Damage to mammalian peripheral nerve fibers activates a growth program in the 
axotomized neuronal cell bodies such that their axons regenerate, provided they find a growth-
permissive substrate. The ideal growth-promoting substrate is provided by the distal segment of a 
lesioned peripheral nerve.  
For this reason, peripheral nerves can be surgically repaired after simple transection injuries by 
reconnecting the individual proximal and distal nerve fascicles. However, when the gap between 
disrupted nerve stumps is too large, the surgeon is required to transplant a segment of an 
autologous nerve that is taken from elsewhere in the patient (Pabari et al., 2010). Since sensory 
nerves such as the sural or peroneal nerve are often used for such procedures, the inevitable 
consequence is the loss of sensory function. Although sensory nerves are routinely transplanted 
even for the repair of motor fibers, experimental data indicate that sensory grafts are less suitable 
than motor nerves (Brenner et al., 2006). The limitation of available donor material for 
autografting and the additional risk of donor site morbidity prompted the need for alternatives to 
the autologous nerve transplantation. Although several alternative tissues have been investigated 
for their potential to support PNS repair, such as muscles or veins (Meek et al., 2004), a major 
research focus has been the development of a bioengineering approach to design artificial nerve 
conduits. Recent advances include internal topographical features that assist in the guidance of 
axonal regeneration. Among these developments, the use of polymeric nanofibers has provided 
one of the most promising templates for the purpose of peripheral nerve repair (Deumens et al., 
2010; Gu et al., 2011). 
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2 Physiological requirements of artificial nerve bridges 
2.1 Peripheral nerve regeneration 
To identify the requirements that artificial nerve constructs must meet in order to substitute 
autologous transplants, a good understanding of peripheral nerve regeneration is important. 
Peripheral nerve injury invariably causes degeneration of the distal nerve stump. Since axons are 
disconnected from their cell somata they are eventually degraded. Cytoskeleton and cell 
membranes are broken up into their molecular constituents. The PNS glia, the Schwann cells, 
shed their myelin. This anterograde degeneration of the distal nerve segments is referred to as 
Wallerian degeneration. It coincides with the infiltration of hematogenous macrophages, which 
clear myelin fragments and neuronal debris. When Schwann cells lose contact with living axons 
they dedifferentiate and proliferate within endoneurial tubes of the nerve. In the process, the 
aligned Schwann cells form the so-called bands of Büngner, which provide an excellent growth 
substrate for axonal regeneration. At the same time, retrograde signals activate a physiological 
program of regeneration in the neurons. Thus, growth cones are formed by severed axons in the 
proximal nerve stump (Figure 1a, b). 
The success of this regenerative response depends on the extent of the injury, especially on the 
maintenance of connections between the proximal fiber fascicles and the endoneurium of the 
severed, distal segments. This kind of injury (called axonotmesis) can be treated conservatively 
because many injured neurons survive, and regenerating axons elongate in contact with the bands 
of Büngner (Sulaiman et al., 2005). Injured peripheral nerves, especially the basement 
membranes, provide an excellent growth substrate for axonal regeneration, where neurite 
extension reaches velocities of several millimeters per day. Subsequently, the Schwann cells re-
myelinate regenerated axons (Boyd and Gordon, 2003). If axons reach their peripheral targets 
they may form new synapses or end organs, and physiological function can be restored (Figure 
1c, d). When the continuity of the endoneurial sheaths is disrupted, if fiber fascicles still remain 
connected via the perineurium or epineurium (neurotmesis) recovery is also possible without 
surgical intervention. After complete transaction, the stumps of the elastic nerves retract, and fiber 
fascicles must be re-aligned and sutured (end-to-end neurorrhaphy) (Sunderland, 1951). Larger 
nerves are supported by endogenous and exogenous blood vessels, and these, too, are surgically 
restored. The problems described above may represent a microsurgical challenge, but do not call 
for a tissue engineering approach. This is the case, however, when the injury causes larger gaps in 
the nerve, where end-to-end suturing would lead to excessive tension, impair microvascular blood 
flow, and result in scarring (Pabari et al., 2010). Any larger lesions are repaired with autologous 
nerve grafts (Deumens et al., 2010) because no better substrate for nerve regeneration is known 
than the injured peripheral nerve itself. 
2 Physiological requirements of artificial nerve bridges 
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Consequently, natural peripheral nerves provide the ideal template for biomimetic designs of 
artificial nerve conduits. Ideally, such constructs would also include molecular signals that guide 
and support regeneration in the natural environment. Since research on molecular processes 
associated with peripheral nerve regeneration has accumulated an immense corpus of data over 
the last half century, I can only mention those pertinent signal transduction pathways that have 
been considered in the functionalization of nerve constructs. 
Figure 1 Peripheral nerve degeneration and regeneration. 
(a) Neurons of the PNS are located in the ventral horns of the spinal cord (motor neurons), the dorsal 
root ganglia (sensory neurons), or the sympathetic chain ganglia (autonomic nervous system). Axons 
are myelinated by Schwann cells. (b) After nerve injury myelin sheaths and axons degenerate distal 
to the lesion site. Schwann cells proliferate, and macrophages remove the debris of degenerating 
fibers. At the lesion site, neurons form axonal growth cones. (c) Axons are able to regenerate along 
longitudinal bands of glia and ECM. Subsequently, Schwann cells remyelinate the new axons. (d) After 
complete transaction proximal and distal nerve stumps retract. Frequently, when axon sprouts fail to 
cross the site of injury, a neuroma forms. The distal part of the nerve and muscle fibers that are no 
longer innervated become atrophic 
Chapter I 
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2.2 Secreted signals in peripheral nerve regeneration 
Axonal injury causes depolarization and action potentials, resulting in an influx of Ca
2+
 ions and 
the activation of an intracellular signal transduction machinery, which regulates formation of the 
growth cone (Makwana and Raivich, 2005). Once axonal growth is initiated, cell survival and 
continued axonal regeneration depend on the supply of trophic physiological growth factors. Most 
of these are synthesized by Schwann cells and, to a lesser extent, by macrophages and possibly 
fibroblasts. Provided that the different subpopulations of peripheral neurons are maintained, 
interactions with the extracellular matrix (ECM) and with other cells guide elongation of the 
nerve fibers. Attempts have been made to incorporate molecular signals that mediate these 
processes in tissue engineered nerve grafts (Gu et al., 2011). 
2.2.1 Regeneration signals that activate axonal growth 
Following the immediate consequences of injury-induced depolarization, the effect of growth 
factors sets in. Perhaps the single most important signaling molecules in this category are ciliary 
neurotrophic factor (CNTF) and nerve growth factor (NGF). The neurocytokine CNTF is strongly 
expressed by myelinating Schwann cells. Although expression of this factor declines after the 
injury, it seems to be released from the damaged cells and triggers neuronal regeneration 
(Sendtner et al., 1992). Another important signal is NGF, a member of the neurotrophin family, 
the expression of which is strongly reduced immediately after the lesion (Heumann et al., 1987), 
and the absence of which may be important for the initiation of the regenerative response 
(Shadiack et al., 2001). Similar observations were made for insulin-like growth factor-I (IGF-I) 
(Kanje et al., 1991). These and related factors at later stages support survival and regeneration of 
injured neurons. 
2.2.2 Survival factors for the damaged nerve cells 
Even in the PNS, with its high regenerative potential, a large percentage of neuronal cell death 
can occur after injury, especially if the lesion occurs close to the cell soma (Deumens et al., 
2010). A number of growth factors were found to be upregulated in regenerating peripheral 
nerves and, as shown by blocking their activity in vivo, to be physiologically neuroprotective. 
Thus, NGF, secreted by Schwann cells, is a neurotrophic factor for sensory and autonomic 
neurons. Leukemia inhibitory factor (LIF), CNTF and glial-derived neurotrophic factor (GDNF) 
support motoneurons. Related molecules, especially the neurotrophins brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3), NT-4/5, the neuropoietic cytokines, e.g. interleukin-6 (IL-
6), and fibroblast growth factors (FGF-1, FGF-2) have also been found to enhance survival of 
PNS neurons (Heumann et al., 1987; Sendtner et al., 1990; Huang and Reichardt, 2001). Most of 
these molecules have been employed in attempts to support regeneration of peripheral nerve (PN) 
injury. A complementary strategy to the supply of survival factors would be to interfere with 
2 Physiological requirements of artificial nerve bridges 
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apoptotic pathways that are also initiated by nerve injury. To my knowledge this has not been 
tested so far in the context of repair strategies with artificial nerve constructs. 
2.2.3 Promoters of axonal regeneration 
Many investigations have been conducted in search of regeneration-promoting molecules in vitro 
and in vivo. Important candidates that were found to be involved in the physiological context are 
IGF-I and IGF-II (Glazner et al., 1993; Emel et al., 2011), both of which are also beneficial when 
given exogenously. BDNF and GDNF are important growth promoting 
factors for motor neurons, especially in the case of chronic deafferentiation (Sendtner et al., 1990, 
1992; Boyd and Gordon, 2003). Although a sufficient supply of these factors in vivo renders 
additional pharmacological application useless to the injured nerve (Gordon, 2010), they may be 
important tools for artificial nerve grafts. NGF is a powerful neuritogenic factor for sympathetic 
neurons (Hoyle et al., 1993). It must be noted that neurotrophins can also have neurotoxic effects 
when they act via the common low affinity NGF (p75) receptor instead of the specific receptor 
tyrosine kinases (trkA, trkB, trkC) (Boyd and Gordon, 2003). Receptors for several GDNF family 
members (c-ret and co-receptors GFRa2, GFRa3) are expressed in small unmyelinated sensory 
neurons in the DRG and in sympathetic ganglia. Their signals enhance regeneration of 
sympathetic and nociceptive neurons (Trupp et al., 1995; Keast et al., 2010). 
2.2.4 Modulators of the Schwann cell response 
Although the effect of neurons on Schwann cells and other non-neuronal cells in the nerve are 
mediated to a large extent by cell surface contacts, soluble factors play a major part. The most 
important inducer of Schwann cell differentiation and myelination is neuregulin-1 of the glial 
growth factor (GGF) family. GGFs are expressed by neurons and have various glia and muscle 
cells as recipients. In the PNS, neuregulin-1 can drive the entire pathway of Schwann cell 
differentiation including axonal myelination (Nave and Salzer, 2006). Neuregulin receptors on the 
Schwann cell are ErbB2/ErbB3 heterodimers, where the ErbB3 subunit binds the ligand while 
ErbB2 has a kinase activity, which initiates the intracellular signaling cascade (Citri et al., 2003). 
Peripheral nerve injury induces expression of neuregulins and their receptors (Carroll et al., 
1997). Other soluble signals include nuclear receptor ligands such as thyroid hormone, estrogen, 
and retinoic acid. Triiodothyronine, estrogen, and progesterone enhance axonal regeneration after 
peripheral nerve injury, though it is questionable whether these hormones are endogenous signals 
in the process (Panaite and Barakat-Walter, 2010). Retinoic acid signaling, which is activated by 
sciatic nerve crush (Zhelyaznik et al., 2003; Zhelyaznik and Mey, 2006) promotes peripheral 
nerve regeneration (Taha et al., 2004) and seems to be a crucial downstream effect of the action of 
neurotrophins (Corcoran and Maden, 1999), especially for NGF- and NT-3-dependent sensory 
neurons (Corcoran et al., 2000). However, retinoid receptor expression is most prominent in 
Schwann cells and macrophages. The transcription factor Krox20, which is an important regulator 
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of peripheral myelination, is activated by neuregulin and retinoic acid via a retinoid X receptor 
(Latasa et al., 2010). 
2.2.5 Signals for vascularization 
Members of the large, heparin-binding fibroblast growth factor family, especially FGF-1 and 
FGF-2 are strong promoters of angiogenesis. Another important paracrine factor in angiogenesis 
is vascular endothelial growth factor (VEGF), which acts downstream of the FGFs, but also has 
parallel, independent effect (Pola et al., 2004; Murakami and Simons, 2008). In addition to these 
primary regulators, synergistic interaction with other factors, including granulocyte colony 
stimulating factor and platelet-derived growth factor, influence blood vessel formation in 
regenerating peripheral nerves (Pan et al., 2009). 
2.3 Surface-bound signals 
If artificial nerve implants are to mimic the physiological stimuli that initiate and maintain 
regeneration in vivo, the most promising molecular candidates would be extracted from this list of 
secreted molecules for intercellular communication. In addition, since axonal growth cones 
advance only in contact with surfaces, regeneration and the infiltration of growth-promoting cells 
depend on the presence of permissive substrates, which interact via surface-bound signals with 
cell membrane receptors. Such substrates are (1) the ECM and (2) the plasmalemma of other 
cells. 
2.3.1 Extracellular matrix 
The predominant growth-permissive surface that renders peripheral nerves such an ideal growth 
substrate is the basal lamina laid down by the Schwann cells. It consists largely of laminin and 
collagen IV (Koopmans et al., 2009). Laminin and collagen are therefore the most frequently used 
ECM proteins in cell culture and three-dimensional constructs (see below). Nerve fibers are 
grouped in distinct fiber fascicles, which are enclosed by a perineurial matrix (endo-, peri- and 
epineurium). This matrix consists of fibrillar collagens type I, III, and V, and of fibronectin, 
which serves as a connecter between cell surface receptors and collagen. The cellular receptors 
for ECM molecules are heterodimeric transmembrane proteins called integrins (Geiger et al., 
2001). Axonal growth cones express integrins that are activated by specific epitopes of these 
ECM molecules. 
Functional integrin receptors consist of one a- and one b-subunit. On one hand, they interact with 
the actin cytoskeleton and, on the other hand, they can activate numerous intracellular signaling 
pathways. Among the two dozen integrins known today the β1-, αv- and α4-containing integrins 
are particularly important as receptors of peripheral nerve ECM. They have multiple functions, 
including the regulation of cell adhesion, cell motility, and differentiation (Hynes, 1992; Geiger et 
al., 2001). A synergism of neuregulin-1, expressed by axons, and the laminins in the basal lamina 
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surrounding the Schwann cells is crucial for regulation of Schwann cell differentiation and 
myelination (Nave and Salzer, 2006). 
2.3.2 Surface-mediated cell–cell interactions 
Several classes of molecules mediate communication between axons, Schwann cells, and other 
cells in the PNS. Since the late 1970s the IgG-domain containing cell adhesion molecules (CAM) 
are known, especially for their role in axonal growth. Important representatives are L1/Ng-CAM, 
N-CAM and transient axonal glycoprotein-1, which appear to support axon fasciculation and 
axonal growth on the surface of non-neuronal cells, including Schwann cells and fibroblasts 
(Bixby et al., 1988; Martini and Schachner, 1988; Martini, 1994; Soares et al., 2005). Related 
myelin-associated glycoprotein and protein zero are present in myelin membranes and are 
important during myelination. 
Cadherins are Ca2+-binding adhesion molecules that mediate homophilic interaction between 
cells. Cadherins are particularly important for selective fasciculation of regenerating axons. For 
instance, E-cadherin mediates attachment of unmyelinated sensory fibers and stabilizes glial 
network (Hasegawa et al., 1996), and N-cadherin mediates axon–Schwann cell interactions during 
regeneration (Bixby et al., 1988; Thornton et al., 2005). 
A lot of research has been done on transcriptional changes and intracellular pathways that 
correlate with axonal regeneration. The intricacies of lesion-induced intracellular signaling can 
only concern us here in so far as these pathways have been considered as targets for 
pharmacological intervention. Suffice it to say that Ras/ERK and PI3K cascades are primarily 
involved, and that Rho–type GTPases (RhoA, Rac, Cdc42) and a panel of phosphorylation-
dependent transcription factors (most importantly STAT-3, ERK), determine neuronal survival, 
the regenerative response of the growth cones, and also are involved in the glial responses 
(Makwana and Raivich, 2005). A considerable overlap and cross-talk between the intracellular 
signaling pathways of all soluble and surface-bound signals has been observed and is far from 
understood. 
2.4 Desired properties of the scaffold 
From the description above I can deduce some functions that artificial implants must fulfill if they 
are to promote nerve regeneration in vivo. A general requirement of biocompatibility, which 
applies to materials implanted anywhere in the body, demands that the implanted construct must 
not induce inflammatory reactions or tumor formation and is not rejected or encapsulated by scar 
tissue. 
2.4.1 Mechanical Properties 
In addition to biochemical signals, mechanical properties are very important because irritation of 
the tissue, e.g., due to stiffness of the material, may cause inflammation or fibrosis. The basic 
design of virtually all artificial nerve guides is a flexible tube, either hollow or filled with interior 
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structures for nerve guidance. The choice of the material for the tube, the dimensions of its wall 
and lumen, as well as the filling determine its biomechanical properties. Implanted devices should 
have a similar degree of flexibility as the natural peripheral nerve, while at the same time they 
must be stable enough not to collapse. The Young’s modulus of various mammalian nerves has 
been determined, so present day scaffolds for implantation are mechanically compatible with the 
surrounding tissue (Deumens et al., 2010; Gu et al., 2011). 
2.4.2 Biodegradability 
It is desirable that the bridge between nerve stumps remains in the body until axonal regeneration 
is completed. Studies with earlier implants, which were made of nondegradable materials such as 
silicone, showed some success, but also revealed disadvantages. The long-term presence of the 
material can elicit an inflammatory foreign body reaction. In several human patients, 
complications with silicon tube implants required follow-up surgery to remove the implants 
(Dahlin and Lundborg, 2001). Thus, recent research studies and most clinical applications 
concentrate on nerve scaffolds that are gradually degraded without the release of toxic products 
(Meek and Coert, 2008b; Meek and Jansen, 2009). 
2.4.3 Permeability for growth factors and gas exchange 
Since regeneration and physiological function of the restored nerve need the exchange of gases, 
water, and biological signals such as hormones or neurotrophins the artificial implant must be 
sufficiently permeable. On the other hand, osmotic influx and swelling might reduce its lumen, 
thereby exerting pressure against 
the regenerating fibers (de Ruiter et al., 2009). This must be avoided. 
2.4.4 Guidance of axon growth and Schwann cell migration 
The central function of the implant, remains, of course, the guidance of regenerating axons from 
the proximal to the distal nerve segment (Dalton and Mey, 2009). Consequently, the growth cones 
have to recognize physical guidance structures, which promote axonal elongation by activating 
specific receptors on the cell membrane. While biochemical signaling between cells and the 
scaffold surface is crucial for any interaction to take place, the physical structure of the implant 
must not only allow infiltration of cells and growth cones but should guide regeneration in the 
longitudinal direction toward the distal end of the implant. Polymeric nanofibers oriented in 
parallel can provide ideal scaffolds in this regard. Finally, axons have to enter into the distal 
fascicles of the existing nerve, which have undergone Wallerian degeneration but still lead to the 
peripheral targets that are to be innervated again. Thus, an additional requirement is that the 
growing axons are not trapped inside the implant. 
As mentioned above, Schwann cells are indispensable not only for the process of axonal 
regeneration but also for the subsequent myelination and maintenance of physiological function. 
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Similar molecular interactions as with neurons should therefore allow migration of Schwann cells 
from the host into the nerve bridge. 
3 Design strategies for artificial nerve bridges 
With respect to the properties of the implant that will determine its success, two aspects can be 
distinguished: first, the physical structure of the scaffold (see Chap.I 3), and second, the 
biochemical functions of its materials (see Chap.I 4). The basic structure of all artificial nerve 
bridges is a tubular graft to connect the proximal with the distal peripheral nerve stump (Figure 
2). 
3.1 Hollow tubes and multichannel nerve conduits 
In the simplest case, a hollow cylindrical tube with a single lumen is used. The original purpose of 
this design was not to replace an entire nerve segment, but only to a bridge a short gap between 
the proximal and distal nerve stumps, then direct ligature of the respective fiber fascicles might 
cause a strain that would interfere with the natural process of regeneration. Different techniques 
have been employed for fabrication of the tube, such as melt extrusion (Chiono et al., 2009), 
particle leaching (Bian et al., 2009), injection molding, and electrospinning: a variety of materials 
were also tested (Meek and Coert, 2008b; Gu et al., 2011). 
Since a hollow tube is the simplest device conceivable as a nerve bridge, this type of implant was 
soon also tried as a long-distance connector when pieces of nerve had to be replaced. Of all 
designs, the empty tube has been tested by far most often in vivo (Figure 2a and 3a, b). The tube 
may consist of natural (Chap.I 4.1) or synthetic materials (Chap.I 4.2) or composites. Although 
case studies with a few patients have been undertaken using more sophisticated designs (Inada et 
al., 2007; Fan et al., 2008), hollow tubes constitute the only nerve guide design that has been used 
in larger clinical trials so far (Meek and Coert, 2008b; Gu et al., 2011). The many cell culture and 
animal experiments that led to the clinical studies will not be reviewed here. 
3.1.1 Empty nerve conduits 
The non-degradable tubes that were first implanted in patients, consisted of silicon (Lundborg et 
al., 1997b, 2004) or polytetrafluoroethylene (Stanec and Stanec, 1998; Pitta et al., 2001). In one 
large study, 26 patients had suffered injuries to the median or the ulnar or to both nerves and 
received tubular silicone implants as nerve bridges. Based on sensory and motor function and 
pain, in 19 cases the outcome of the operation was rated very good or good; however, the implant 
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had to be removed in seven cases because of discomfort caused by the silicone tube (Braga-Silva, 
1999). There are divided opinions about whether non-degradable implants are advisable because 
they may cause a foreign body reaction, and whether the need to remove them in a subsequent 
operation after regeneration is risky (Lundborg et al., 1997b). However, even Lundborg and 
colleagues who have conducted successful clinical trials with silicon tubes state a preference for 
Figure 2 Design strategies for artificial nerve bridges. 
(a) Empty tube used for bridging gaps between proximal and distal nerve stumps; (b) tubular 
implant with multiple intraluminal channels (e.g., de Ruiter et al., 2008; Yao et al., 2010); (c) aligned 
microfibers as longitudinal guidance structures (e.g., Kim et al., 2008; Ribeiro-Resende et al., 2009); 
(d) hydrogel filling of the conduit (e.g., Inada et al., 2004; Labrador et al., 1998); (e) sponge filled tube 
(e.g., Inada et al., 2004; Toba et al., 2001); (f) longitudinally oriented pores within the scaffold (e.g., 
Ceballos et al., 1999; Möllers et al., 2009); (g) modification of the inner side of the tube with bioactive 
coating (e.g., Chew et al., 2007; Shen et al., 2010) 
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biodegradable materials, provided their degradation does not cause further complications (Dahlin 
and Lundborg, 2001). Thus, to date, biodegradable materials are the preferred solution. Three 
types of such tubes have been approved for implantation in humans and are commercially 
available. They have been tested in several hundreds of patients.  
NeuraGen, consisting of type I collagen, is produced by Integra Neuroscience (www.integra-
ls.com). In the largest study so far, NeuraGen implants were used mostly for bridging sensory 
nerves of the arm. Twenty-six patients were evaluated quantitatively to assess functional recovery 
of nerve transmission. In 45 % of the patients an improvement of sensory functions was seen 
(Wangensteen and Kalliainen, 2010). In a number of small clinical trials and case studies, the 
collagen implant has demonstrated its usefulness (Ashley et al., 2006; Lohmeyer et al., 2007; 
Farole and Jamal, 2008; Taras and Jacoby, 2008), though occasional failures were also reported 
(Moore et al., 2009). In this latter report, another nerve conduit, Neurotube, was also tested, 
though without better outcome. 
Neurotube is a poly(glycolic acid) (PGA) implant, produced by Synovis Life Technologies 
(www.synovismicro.com). It has been tested in several clinical studies. In one of these, a group of 
46 patients received Neurotube implants for lesions of nerves innervating the hand. The results 
showed good to excellent outcome in 74 % of the cases, which was not statistically different from 
a control group who received autologous nerve transplantations (Weber et al., 2000). Other 
successful studies with the PGA tubes have been published, with repair of median, ulnar, and 
facial nerves being reported (Navissano et al., 2005; Donoghoe et al., 2007; Agnew and 
Dumanian, 2010). 
The third commercially available nerve scaffold is Neurolac, produced by Polyganics 
(www.polyganics.com). It consists of a poly(lactic acid)/poly(ε-caprolactone) blend (PLA/PCL). 
So far, two clinical studies and case reports have been published, with a total of 36 patients. 
Although in the first report from 2003 no nerve regeneration was found, the second study reported 
functional regeneration similar to results with autologous nerve transplants (Bertleff et al., 2005). 
Again, failures to achieve recovery of sensory functions were reported, e.g., with digital nerve 
reconstruction in the foot (Meek et al., 2006). 
3.1.2 Multichannel devices 
Without changing the basic design, tubular implants have been constructed to incorporate several 
intraluminal channels that can accommodate different fiber fascicles within a peripheral nerve 
(Figure 2b and 3c, d). Multichannel implants with up to seven compartments were produced using 
a similar injection-molding technique as for the implant with a single lumen (de Ruiter et al., 
2008; Yao et al., 2010). On the level of fiber fascicles, the multichannel devices appeared to 
reduce mixing of regenerating axons. Necessarily, these constructs reduced the available space 
within the implant; and when numbers of regenerated fibers and behavioral improvement were 
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evaluated, the multichannel constructs were no better than hollow tubes (Yao et al., 2010). An 
alternative construction design achieved the similar effect of longitudinal divisions of the 
otherwise empty tube by integrating one or a few films into the construct. When tested in rat tibial 
nerves, tubes with one film, i.e., just two compartments, were better than implants with none or 
three films (Clements et al., 2009). 
In animal experiments, many studies were performed with hollow tubular implants to assess the 
biocompatibility of the material. Most often, grafts were tested as bridges of the sciatic nerve, and 
by far most experiments were done with rats where nerve lesions rarely exceeded 20 mm. When 
short nerve gaps are bridged with tubular implants, a fibrin matrix will fill this distance and allow 
infiltration of Schwann cells from the nerve stumps. These cells can then form orientated bands of 
Büngner, which may guide regenerating axons. Experiments with rabbits, cats, dogs, and 
monkeys indicate that internal guidance structures are needed for larger cell-free implants (Brown 
et al., 1996; Matsumoto et al., 2000; Ding et al., 2010). An extensive list of animal studies with 
further references is given in a recent review (Shin et al., 2012). The construction of three-
dimensional guidance structures remains a technical challenge, where polymeric nano- and 
microfibers take center stage. 
Figure 3 Examples of artificial nerve guides that were successfully tested in animal 
experiments. 
(a) SEM images of a nerve tube consisting of electrospun PLGA/PCL microfibers; scale bar 500 µm 
(Panseri et al., 2008). (b–d) Collagen conduits with one or multiple interior channels were fabricated 
from molds with insertion of stainless wires; scale bar 1 mm (Yao et al., 2010). (e) Composite nerve 
conduit of several hundred PCL filaments each having six leaflets in cross-section (insert); scale bar 
150 µm (Whitlock et al., 2009). (f) Poly(glycolic acid) tubes filled with collagen sponge were 
successfully used to bridge 80 mm gaps of canine peroneal nerves (Nakamura et al., 2004). (g) 
Collagen scaffold produced with directional freezing; longitudinal sections demonstrate oriented 
channels; extensive fenestration between adjacent channels can also be seen; scale bars 50 µm 
(Möllers et al., 2009). 
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3.2 Structured implants with polymeric fibers 
One successful strategy to provide such guidance structures in the longitudinal direction of the 
implant is the use of polymer fibers (Figure 2c and 3e). These can be produced by a number of 
different techniques such as drawing, template synthesis, phase separation, self-assembly, and 
electrospinning. Historically, large diameter fibers were tested first. Lundberg and coworkers 
filled silicone tubes with eight longitudinally oriented polyamide filaments of 250 µm diameter as 
implants. Across a 15 mm gap in the rat sciatic nerve, this device was a substantial improvement 
compared with hollow implants (Lundborg et al., 1997a). To mimic the natural situation, many 
more and thinner fibers would provide topological cues and induce the formation of many 
longitudinal strands of Schwann cells. Cell culture experiments demonstrated that small caliber 
fibers (5–30 µm) had a stronger effect on the orientation of growing neurites than thicker fibers 
(500 µm) (Smeal et al., 2005). In the context of peripheral nerve regeneration, the technique that 
has been used most frequently for the manufacturing of small diameter fibers is electrospinning. 
3.2.1 Electrospinning of nano-/microfibers 
As a process to produce continuous fibers with very small diameters, electrospinning has been 
known for more than a century. During the last two decades, the method has become increasingly 
popular in the field of bioengineering because the method is easy to use, very flexible with respect 
to fiber configuration in situ, and a great range of different materials can be used (Teo and 
Ramakrishna, 2006). Biodegradable polymers that have been spun to nanofibers, tested in vitro, 
and implanted in the nervous system will be discussed below. The typical electrospinning set-up 
in a research laboratory consists of a high-voltage power supply (up to 30 kV), the spinneret (a 
syringe with a flat tip needle), and collector electrodes (Figure 4). To induce formation of fibers, a 
high voltage is applied via the spinneret to the polymer solution. This causes electrostatic 
repulsion within the charged solution, which is stronger than its surface tension, such that a jet 
erupts from the spinneret. At some distance, the jet enters a stage of bending instability, is 
stretched under electrostatic forces toward the grounded target electrode, and the solvent 
evaporates. With a low flow rate, polymer solution is pumped through the spinneret to ensure 
continuous formation of fibers, which accumulate on the target. On a single plate electrode, used 
as a target, mats of randomly coiled fibers accumulate. Several electrospinning devices were 
tested in order to assemble nanofibers that are aligned in a parallel orientation. Rotating drums in 
different configurations were devised by several groups (Matthews et al., 2002; Chew et al., 2005; 
Kim et al., 2008). Alternatively, two parallel bars can be used as target electrodes, such that 
parallel fibers accumulate between them (Schnell et al., 2007; Klinkhammer et al., 2009). Using 
such devices, parallel fibers of diameter from less than 100 nm to more than 5 µm can be 
produced from various synthetic polymers. A good review with drawings of various devices has 
been written by Teo and Ramakrishna (Teo and Ramakrishna, 2006).  
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Electrospun micro- and nanofibers have high surface-to-volume ratios and provide growth 
substrates for many neural cell types (Gerardo-nava et al., 2009; Bockelmann et al., 2011). Films 
of electrospun fibers have been used to produce tubular implants and to subdivide nerve conduits 
into longitudinal compartments (Clements et al., 2009). The specific advantage of nanofibers is, 
of course, their property as individual guidance structures (Lietz et al., 2006; Kim et al., 2008). In 
one study, PGA microfibers were incorporated in a chitosan tube as implants to bridge 30 mm 
gaps in the sciatic nerve of beagles. The dogs, which were investigated after 6 months, recovered 
function of the operated nerves. Skeletal muscles were re-innervated, and the artificial constructs 
were completely degraded within the half year time-frame of the study (Wang et al., 2005). A 
different research team stacked films of parallel fibers consisting of poly(acrylonitrile-co-methyl 
acrylate) (PAN-MA) inside a polysulfone tube. These constructs were implanted in rats to bridge 
sciatic nerve gaps of 17 mm. Sixteen weeks after surgery, target muscles were found to be 
innervated again, and regeneration of sensory and motor nerve fibers could be demonstrated (Kim 
et al., 2008). This represented a significant progress because the scientists incorporated oriented 
nanofibers in a three-dimensional design. The largest distance of nerve repair has been reported 
by Matsumoto, Toba and coworkers, who were able to bridge an 80 mm gap of the peroneal nerve 
in dogs (Matsumoto et al., 2000). Their conduits consisted of tubes of PGA/collagen blend, filled 
with laminin-coated collagen fibers. Regeneration was assessed histologically, 
electrophysiologically, and with behavioral testing. Very sophisticated guidance structures have 
Figure 4 Electrospinning of aligned fibers. 
The electrospinning set-up used by the authors consists of a high voltage power supply (e.g., 20 kV), 
the spinneret (a syringe with a flat tip needle) connected to a pump (flow rate e.g., 1 mL/h) and 
parallel bars as target electrodes to collect parallel fibers (Schnell et al., 2007; Klinkhammer et al., 
2009). Another frequently used device to assemble aligned fibers is the rotating drum (Matthews et 
al., 2002; Chew et al., 2005; Kim et al., 2008). Scanning electron microscopy images show 
PCL/collagen fibers collected between parallel bars (Gerardo-nava et al., 2009) 
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been developed by Schlosshauer’s group, who also tested functionalization with NGF, 
transforming growth factor-b1 (TGFb) and laminin in their experiments. Oriented PCL filaments 
were made by melt extrusion using nozzles with six-leaf cross-sections. This resulted in yarns of 
several hundred filaments, each with six longitudinal grooves (Figure 3e), which caused the 
alignment of Schwann cells, “artificial bands of Büngner” (Ribeiro-Resende et al., 2009). As also 
observed by others (Schnell et al., 2007), the topographic effect of the substrate on glia cells 
indirectly affected the orientation of growing axons that need not have any contact with the fibers 
themselves. 
3.2.2 Self-assembling peptide scaffolds 
The manufacture of self-assembling nanofibrous scaffolds is based on repetitive peptides that 
consist of alternating hydrophilic and hydrophobic amino acids and spontaneously form stable b-
sheet structures. The self-assembling process takes place when the aqueous peptide solution is 
introduced to a physiological salt-containing solution (i.e., saline, tissue culture media, 
physiological solutions, or body fluids such as cerebrospinal fluid) and is mediated by non-
covalent bonds, such as van der Waals forces, hydrogen bonds, and electrostatic forces. As a 
result of hydrophobic interactions, different b-sheets pack together and form double layered β-
sheet nanofibers with diameters of about 10 nm, much smaller than typical electrospun nanofibers 
(Gelain et al., 2007; Cao et al., 2009). Scaffolds based on self-assembled peptides provide several 
advantages over other biomaterials for their potential use as bridging materials for the nervous 
system: 
1. Their three-dimensional environment has dimensions that are similar to the 
native ECM in peripheral nerves. 
2. The peptides can be degraded into natural L-amino acids that are nontoxic and 
may be recycled by surrounding cells. 
3. They elicit only a minor, if any, inflammatory or immune response. 
4. Modifications at the single amino acid level are possible, and various functional 
motifs can be added to promote neurite outgrowth. 
5. The self-assembly process takes place under physiological conditions without 
the need of temperature changes (Gelain et al., 2007, 2010). 
 
Several cell culture studies demonstrated that scaffolds made via self-assembling peptides provide 
permissive substrates for cell attachment and growth as well as support for extensive neurite 
outgrowth and synapse formation (Holmes et al., 2000; Silva et al., 2004; Ellis-Behnke et al., 
2006), including the migration of Schwann cells and axonal regeneration from DRG neurites 
(DRG) (McGrath et al., 2010). Fewer reports have been published where such scaffolds were used 
in the nervous system in vivo. In one study of CNS repair, a knife wound in the visual system of 
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2-day-old hamsters was successfully treated by injection of peptide solution into the lesion site. 
Here self-assembling nanofiber scaffolds provided a permissive substrate for axonal regrowth, 
and visual function could be restored (Ellis-Behnke et al., 2006). Peptide scaffolds implanted after 
spinal cord dorsal column transection injuries of rats integrated very well with the host tissue and 
supported the infiltration by blood vessels and axons (Guo et al., 2007). To my knowledge, only 
one in vivo study focused on the potential of self-assembly nanofibers to repair a peripheral nerve 
(McGrath et al., 2010). In this report, a 10 mm gap of the rat sciatic nerve was successfully 
bridged with a tubular conduit filled with a self-assembling peptide nanofiber scaffold. The 
distance of axonal regrowth 3 weeks after implantation was significantly enhanced by these 
conduits when compared to control implants filled with alginate/fibronectin hydrogels, and 
recovery of gastrocnemius muscle function was also better. However, grafted Schwann cells 
improved the efficacy of the implants, and autologous nerve grafts still yielded the best outcome 
(McGrath et al., 2010). Although these investigations demonstrated that self-assembling peptide 
scaffolds can serve as permissive substrate in regenerative medicine, the nanofibers of these 
constructs lack orientation. This is a desired property for long distance guidance within an 
artificial nerve bridge, which is more easily achieved with the electrospinning method. 
3.3 Structured implants with gels and scaffolds 
A completely different approach for the internal structure of implants consists in gel scaffolds 
with a narrow mesh of longitudinal pores or channels. Several laboratories used collagen 
hydrogels to fill the lumen of different nerve guides, which themselves were made from a range 
of biocompatible materials (Figure 2d). Based on histology and measurements of functional 
recovery, such hydrogel fillings of collagen or laminin proved superior in comparison with saline-
filled implants. It is interesting to note that lower concentrations of collagen- or laminin-
containing gels (e.g., 1.28 mg/ml collagen, 4 mg/ml laminin) supported better functional recovery 
than high gel concentrations (e.g., 1.92 mg/mL collagen and 12 mg/ml laminin) (Labrador et al., 
1998; Verdú et al., 2002). 
Scientists from the University of Kyoto constructed a sophisticated nerve conduit that consists of 
a polyglycolic acid tube, filled with a sponge of porcine collagen soaked with laminin (Figure 2e 
and 3f) (Toba et al., 2001; Inada et al., 2004). Tubes of 3–4 mm inner diameter were implanted as 
bridges into the peroneal nerves of beagle dogs. On the basis of histological and 
electrophysiological evaluation, these implants were even superior to nerve autografts, although 
some cases of neuromas occurred (Inada et al., 2004). Consequently, similar tubes were implanted 
for repair in human patients. In two women, the frontal branch of the facial nerve was restored 
with the construct. Five months after surgery both were able to lift their eyebrows symmetrically. 
Electrophysiological tests showed recovery of compound muscle action potentials with normal 
latency (Inada et al., 2007). This success was possible with the repair of small caliber nerves, 
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which also showed the best prognosis using hollow tubular implants. Nevertheless, the outcome 
and the previous animal experiments, where bridges of up to 80 mm were implanted in dogs 
(Toba et al., 2001; Siemionow et al., 2010), demonstrated that the inclusion of a collagen matrix 
was a substantial advancement. 
While these results are already very impressive, additional improvement is expected with the 
design of gels with a fibrillar network that is oriented in the longitudinal direction of the nerve 
guide (Figure 2f). One idea to achieve this is the application of strong magnetic fields that can 
orient collagen or fibrin matrices. Such scaffolds promoted neurite elongation from chick DRG in 
the desired direction (Dubey et al., 1999). In mice sciatic nerves, magnetically aligned collagen 
gels supported regeneration and remyelination of axons over a 6 mm gaps better than control 
tubes (Ceballos et al., 1999). 
Another, very promising technique is controlled freeze drying of collagen suspensions (Figure 
3g). When solvent is caused to freeze from one side of the solutions, collagen is displaced to the 
side, thus resulting in walls of orientated guidance channels. The diameter of these longitudinal 
pores can be controlled in the range of 20–120 µm. In vitro studies have already demonstrated 
that such scaffolds can be easily infiltrated by Schwann cells, fibroblasts and regenerating axons, 
which follow the desired orientation of the scaffold (Bozkurt et al., 2007, 2009; Möllers et al., 
2009). Three-dimensional constructs produced with this method are commercially available 
(Matricel www.matricel.net) and have been tested successfully in animal experiments (Bozkurt et 
al., 2012). 
3.4 Implantation of cells with artificial nerve bridges 
The closest thing to real nerve transplants are artificial constructs that are preseeded with growth 
promoting cells, and many researcher believe that gaps longer than 30 mm will not be 
successfully repaired unless supporting cells are included in the scaffold (Hood et al., 2009; 
Deumens et al., 2010). These cells may derive from the host organism itself or from cultures. 
They are intended to release physiological signals, many of which may be unknown and thus 
cannot be mimicked with chemical modification of the implant material. Best suited for this 
purpose are Schwann cells because they naturally populate the PNS, where they serve a number 
of important functions during regeneration. As discussed above, Schwann cells secrete the basal 
lamina that serves as axon guidance substrate, synthesize a host of necessary growth factors, and 
even participate in the clearance of myelin debris. Later, they are required for myelination of the 
regenerated fibers (Boyd and Gordon, 2003). Unfortunately, isolation of Schwann cells from a 
peripheral nerve and expansion in culture are time-consuming and also carry the risk that culture 
conditions alter the cellular phenotype. 
Other cell sources have therefore been explored as alternatives. They include olfactory 
ensheathing cells, embryonic stem cells, mesenchymal stem cells (Gu et al., 2011; Radtke et al., 
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2011), and even cell lines such as the immortalized SCTM41 Schwann cells (Lago et al., 2009). 
Genetic modification has been considered for implanting cells as a constant source of growth 
factors. Most often, fibroblasts have been engineered with this intention, e.g., to produce 
neurotrophins, CNTF and FGF-2 (Sørensen et al., 1998; Schmidt and Leach, 2003). 
The majority of studies on PN regeneration, however, used Schwann cell primary cultures 
(Guénard et al., 1992; Kim et al., 1994; Brown et al., 1996; Sørensen et al., 1998; May et al., 
2004; Radtke et al., 2005; Lohmeyer et al., 2007; Sinis et al., 2007). Unfortunately, the 
implantation of any type of living cells is not without complications. First, the purity of the 
primary culture is essential because the cells must not be contaminated, e.g., by fibroblasts in a 
Schwann cell culture. Second, immune rejection of the cells is an issue. Heterologous 
transplantation poses less of a problem between inbred strains of mice and rats, but it would 
require immune suppression in humans. Ideally therefore, the cells would have to be taken from 
the same patient who requires the PN implant. For a potential therapy of CNS lesions, an 
interesting strategy is the preparation of olfactory ensheathing cells from the human olfactory 
epithelium. In many physiological respects these glial cells are similar to Schwann cells (Kawaja 
et al., 2009), and the cells could be prepared for autologous implantation. Olfactory ensheathing 
cells are therefore being explored as a possibility to produce better implants also for peripheral 
nerves (Radtke et al., 2011). Nonetheless, because of the fundamental difficulties of immune 
rejection when foreign tissues are implanted, I consider the development of cell free artificial 
nerve bridges as an important goal. Ideally, scaffolds of different lengths and diameters could be 
produced in advance and stored to be implanted on demand. 
4 Materials for artificial nerve conduits 
Biocompatible materials are needed for the two essential components of the artificial nerve 
bridge, i.e., the surrounding tube and its interior structure, the latter being either linear filaments 
or a scaffold with longitudinal pores. The selected material will determine not only the 
biochemical interaction between cells and graft but also the physical properties of the implant. 
4.1 Natural materials 
Many natural materials are hydrophilic and show excellent biocompatibility. Proteins and 
carbohydrates of high molecular weight are extracted rather than synthesized chemically. On the 
down side, when the material is derived from mammalian tissue there is a certain risk of disease 
transmission and/or allergic reactions. Nevertheless, many biologically derived materials have just 
the desired properties for applications in nerve repair. 
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4.1.1 Extracellular matrix proteins 
The most straight forward approach is to use ECM material that gives structure to the peripheral 
nerves in situ. Epineurium, perineurium and endoneurium consist largely of one family of ECM 
proteins: collagen. 
Collagen 
Of all biologically derived material used in bioengineering, collagen is the most popular, not only 
for PN conduits but for tissue reconstruction in many other applications. Collagens, which 
account for more than a quarter of total body protein, are extracellular proteins with a 
characteristic triple helix structure of three either identical or heteromeric a-chains (Koopmans et 
al., 2009). Of at least 29 different forms, collagen I, III, and V form fibrils in the ECM of the 
PNS. The non-fibrillar collagen IV is present in the basement membranes secreted by Schwann 
cells. In vitro, collagen IV has superior qualities as a substrate for axonal growth, but the fibrillar 
collagen I is more often used in scaffold production. As reviewed above, collagen has been used 
to form tubular implants, e.g., NeuraGen (Ashley et al., 2006; Farole and Jamal, 2008; Taras and 
Jacoby, 2008; Wangensteen and Kalliainen, 2010). It is also one of the materials frequently used 
for interior guidance structures (Figure 3b–d, f, g): During matrix formation, collagen hydrogels 
can be oriented with strong magnetic fields (Ceballos et al., 1999), and collagen sponges 
combined with laminin (Toba et al., 2001; Inada et al., 2004) or chondroitin-6-sulfate 
(Chamberlain et al., 1998) were very successful as nerve guides in animal experiments. Using the 
directional freezing technique, scaffolds with longitudinally oriented pores were created and 
tested for implantation in PNS and CNS (Bozkurt et al., 2007, 2009; Möllers et al., 2009). It is 
also possible to produce collagen nanofibers by electrospinning (Matthews et al., 2002). Even 
blends with other polymers (e.g., 25 % collagen, 75 % PCL) were significantly better for axon 
guidance and Schwann cell migration than control fibers without collagen (Schnell et al., 2007). 
Fibronectin 
Axons and glia cells interact with the ECM via their integrin receptors. Although integrins can 
directly bind to some epitopes on collagen, an important intermediate molecule between collagen 
and the cells is the 440 kDa glycoprotein fibronectin, which is also part of the basement 
membrane. It is primarily produced by fibroblasts. In addition, there is a soluble dimeric form of 
fibronectin in the plasma, which together with fibrin has an important function in wound healing 
(Pankov and Yamada, 2002). The biological activity of fibronectin has been shown to be strongly 
influenced by the conformation of underlying surfaces (Dalton and Mey, 2009). Fibronectin 
conduits have performed well in PN repair. For instance, tubular implants filled with a solution of 
fibronectin, laminin, and fibronectin/laminin mixture permitted regeneration across an 18 mm gap 
in rat sciatic nerves, and all of these ECM molecules promoted migration of Schwann cells into 
the conduit (Bailey et al., 1993). 
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Laminin 
This is the most important component of the basal lamina. Different laminins exist, all of which 
are large glycoproteins (500–1,000 kDa) that consist of three polypeptide chains (α, β, and γ). 
Applied in gels or solution together with collagen and other proteins, laminin enhanced nerve 
regeneration in vivo and in vitro. In addition to the whole protein, integrin-activating peptide 
sequences from laminin were identified that also mediate cell adhesion and growth. Well-
characterized sequences are those containing Arg-Gly-Asp (RGD, in one letter code) in laminin a-
chains (Hersel et al., 2003); YIGSR, located on the β1-chain; and IKVAV, which is present near 
the C-terminal end of the α1-chain, close to a heparin-binding domain (Dalton and Mey, 2009). 
When synthetic polymer fibers were functionalized with GRGDS, adhesion and speed of axonal 
growth cones and of migrating cells were significantly enhanced (Bockelmann et al., 2011). 
Laminins have already been used for a long time as substrates in cell culture experiments. The 
commercially available Matrigel is a non-defined ECM solution derived from a mouse sarcoma 
cell line. Its main component is laminin, but Matrigel also contains collagen IV, heparan sulfate 
proteoglycans, and several growth factors. Used as a thermoreversible gel it is liquid at low 
temperatures and solidifies at body temperature. As a filling in fiber containing implants, Matrigel 
supported regeneration in the mouse sciatic nerve. Electromagnetic alignment of the material 
further improved the outcome (Verdú et al., 2002; Lohmeyer et al., 2007). 
4.1.2 Other natural proteins 
Fibroin (Silk) 
Silk is not immunogenic and has high tensile strength, toughness, and elasticity (Deumens et al., 
2010). Its core structural protein is fibroin, extracted from the cocoons of Bombyx mori 
caterpillars (silkworm). The protein exhibited good biocompatibility with Schwann cells and 
DRG (Yang et al., 2007). Fibroin was used for electrospinning of nanofibers (Madduri et al., 
2010b). A tubular fibroin construct, filled with about 20 longitudinally aligned fibroin fibers was 
implanted as a 10 mm nerve bridge in rats and evaluated after 6 months. The detailed anatomical 
evaluation demonstrated excellent results, though autologous nerve grafts were still superior 
(Yang et al., 2007).  
4.1.3 Polysaccharides 
One risk with the implantation of foreign ECM proteins is development of scar tissue within the 
regenerating area. This acts as a physical barrier to axonal elongation between the nerve stumps. 
It appears that this problem is less likely with biocompatible polysaccharides. 
Chitin and chitosan 
The exoskeleton of arthropods consists largely of chitin, which is also present in the cell walls of 
fungi. Second only to cellulose, chitin is the most abundant polysaccharide found in nature. The 
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monomeric building blocks of chitin are N-acetyl-D-glucosamine. Chitosan, a linear copolymer of 
N-glucosamine and N-acetyl-D-glucosamine, is prepared via partial deacetylation of chitin. Due 
to similarities with glucosaminoglycans side chains of ECM glycoproteins (e.g., chondroitin 
sulfate, heparin sulfate, keratan sulfate), chitosan can interact with fibronectin, laminin, and 
collagen. It has been used extensively in biomedical applications including nerve conduits (Wang 
et al., 2005; Gu et al., 2011). In one construct, a double-layered tube was devised comprising an 
outer chitosan film for mechanical strength and an inner layer of electrospun chitosan fibers 
(Figure 2g). In addition, extended YIGSR peptides were covalently bound to the chitosan fibers to 
enhance interaction with cells. As 10 mm peripheral nerve guides in rats, these constructs were 
successful as autografts (Itoh et al., 2005; Wang et al., 2008). When chitosan/PLGA implants 
were complemented with bone marrow-derived stem cells, even 50 mm sciatic gaps in dogs could 
be repaired almost as well as with autologous nerve transplants (Ding et al., 2010). Chitosan 
scaffolds were also prepared with longitudinal pores, which improved regeneration and functional 
recovery (Huang et al., 2010). In other experiments, chitin/chitosan implants caused infiltration of 
many inflammatory macrophages, and modification of the material was therefore considered 
(Huang et al., 2010). 
Alginate and agarose 
Alginate, extracted from brown seaweed, consists of repeat units of mannuronic acid and 
glucuronic acid. Having free carboxyl groups it can be cross-linked in the presence of calcium. 
Most often, alginate is used as a gel inside implanted nerve tubes (Suzuki et al., 1999; Ohta et al., 
2004); however, alginate gel has been used as glue to connect nerve stumps 7 mm apart (Suzuki et 
al., 2000), and hollow tubes were made of freeze-dried alginate/chitosan blend. For the delivery of 
a growth factor, nerve tubes were filled with alginate and implanted in a rat sciatic nerve model. 
This study showed that regeneration was better in empty conduits, suggesting that the presence of 
alginate actually impeded regeneration (Mohanna et al., 2003). Agarose is also extracted from 
seaweed and has been used extensively for cell cultures (Dalton and Mey, 2009). In the context of 
artificial nerve implants, an interesting application has been the use of agarose as a material for 
creating concentration gradients of growth factors (Mohanna et al., 2003, 2005). 
Hyaluronic acid 
Another important glucosaminoglycan of the ECM in connective tissues, especially cartilage and 
skin, is hyaluronic acid. It consists of repeating disaccharide units of D-glucoronic acid and D-N-
acetyl-glucosamine. For biomedical applications, hyaluronic acid gels proved to be useful because 
the molecule is involved in many aspects of wound repair, including angiogenesis, reduction of 
scar formation, and moderation of the inflammatory reaction. A positive effect on PN 
regeneration was achieved with local application (Ozgenel, 2003). Hydrogels consisting of 
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hyaluronic acid and ECM proteins were used as carrier matrix in cell-based repair strategies for 
the PNS (Suri and Schmidt, 2010). 
4.1.4 Self-assembling peptide scaffolds 
As a new strategy in the design of scaffolds for nerve repair, self-assembling peptide nanofibers 
have already been mentioned above. They consist of natural amino acids and form a three-
dimensional network of nanofibers through spontaneous self-assembly. The ability of EAK16-II 
(AEAEAKAKAEAEAKAK; one-letter amino acid code for Glu, Ala, Lys), a 16 amino acid 
peptide derived from the yeast protein zuotin, to self-assemble into a nanofibrous scaffold was 
observed serendipitously when the peptide was tested for its cytotoxicity in cell culture (Zhang et 
al., 1993). This finding has inspired the development of a number of additional self-assembling 
peptides including RADA16-I (AcN-RADARADARADARADA-CNH2) and RADA16-II (AcN-
RARADADARARADADA-CNH2), in which Arg (R) and Asp (D) residues substitute Lys and 
Glu (Holmes et al., 2000). Studies, which demonstrated the compatibility of self-assembling 
peptides with neural tissue were cited above. In a few experiments, these were tested for nerve 
repair (Rafiuddin Ahmed and Jayakumar, 2003; Silva et al., 2004; Ellis-Behnke et al., 2006; 
McGrath et al., 2010). The RADA16 self-assembling peptide solution has been developed into a 
commercial product intended for wound repair and three-dimensional cell cultures (3DM, 
www.PuraMatrix.com). 
4.2 Synthetic polymers 
In comparison with biologically derived materials, synthetic polymers have several advantages 
and disadvantages. Since they do not need to be extracted from animal tissue they pose a lower 
risk of contamination and immunological reaction. Their physical and chemical properties can be 
better controlled and manipulated. On the other hand, synthetic materials usually do not activate 
specific cellular receptors and therefore do not by themselves elicit the desired cellular responses 
such as axonal growth or cell migration. Some materials may even be rejected or encapsulated in 
scar tissue. 
4.2.1 Non-degradable materials 
The first generation of tubular implants for PN repair were made of silicone rubber, which 
showed some success (Lundborg et al., 1982, 1997b, 2004; Braga-Silva, 1999). Another non-
degradable material is poly(acrylonitrile-co-methylacrylate) (PAN-MA). Recently, a peripheral 
nerve conduit was designed by stacking oriented, electrospun PAN-MA fibers in the two halves 
of a longitudinally split polysulfone tube, which were resealed and implanted as a sciatic nerve 
bridge in rats. In the absence of additional cells or growth factors this construct supported 
excellent regeneration, which was monitored with histological, physiological, and behavioral 
methods (Kim et al., 2008). This and other studies (Clements et al., 2009) demonstrated the 
advantage of three-dimensional arrays of nanofibers as guidance structures in vivo (Figure 5). 
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Other non-degradable materials used for nerve implants are extended poly(tetrafluoroethylene) 
(ePTFE, Gore-Tex) and poly(urethane) (Stanec and Stanec, 1998). Since non-degradable 
materials may cause a chronic foreign body reaction and therefore need to be removed in a second 
operation, they are no longer a preferred strategy for artificial nerve implants (Gu et al., 2011). 
4.2.2 Aliphatic polyesters 
Perhaps the most important category of biodegradable synthetic polymers with favorable 
characteristics for nerve repair is that of aliphatic polyesters. The most important examples are 
poly(a-hydroxy acids), i.e., poly(lactic acid) (PLA, with stereoisomers PLLA, PDLA), 
poly(glycolic acid) (PGA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL), and 
poly(hydroxybutyric acid) (PHB). The compounds are completely biodegradable via hydrolytic 
digestion, and many cell culture experiments demonstrated excellent biocompatibility with nerve 
tissue of PLA (Yang et al., 2005; Liu et al., 2011), PGA (Ichihara et al., 2009), PLGA (Bini et al., 
2004; Ding et al., 2010; Yucel et al., 2010), PCL (Schnell et al., 2007; Klinkhammer et al., 2009; 
Wang et al., 2009), and PHB (Mohanna et al., 2003, 2005; Aberg et al., 2009). However, they are 
not soluble in water, do not directly activate biological signals, so possibilities for conjugation 
with functional peptides are limited. For nerve bioengineering purposes, poly(a-hydroxy acids) 
are dissolved in non-aqueous solvents and spun to fibers that can be used as material for the nerve 
tube or as oriented guidance structures for growing axons and cells. Fibers can also be spun 
directly from the polymer melts. Often blends of different polymers or blends with biologically 
derived materials have been used successfully. A few important examples are given below, but, as 
many other studies could be cited, this selection is somewhat arbitrary. 
Poly(L-lactic acid) 
Cai and coworkers produced porous tubular PLA conduits, which had an internal structure of 
aligned PLA filaments. Ten weeks after implantation in a rat sciatic nerve lesion model, this 
implant supported axon regeneration and remyelination much better than silicone conduits in 
comparison (Cai et al., 2005). Tubes consisting of collagen-coated PGA and braided PLA/PGA 
were compared in dogs for 40 mm repair of the peroneal nerve. Regeneration, including recovery 
of muscular function after 12 months, was best in PLA/PGA-collagen tubes, where it reached 
80 % of the positive control (Ichihara et al., 2009). 
Poly(lactic-co-glycolic acid) 
With electrospinning, PLGA fibers were collected on a rotating mandrel, and tubular nerve 
conduits from this material were tested as 10 mm bridges in the rat PNS. One month after 
implantation, no inflammatory response was recorded but successful regeneration was observed 
only in 5 of 11 rats (Bini et al., 2004). Substantial improvements were possible with combinations 
of PLGA and chitosan, coated with CNTF. Histological evaluations showed that such an implant 
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was able to induce regeneration across a 25 mm tibial nerve gap. In a canine model, the conduit 
was as good as the autologous nerve transplant (Shen et al., 2010). 
Poly(ε-caprolactone) 
Electrospun PCL fibers alone are good substrates for axonal regeneration and the migration of 
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various glial cells (Gerardo-nava et al., 2009). These properties are significantly improved via 
blending with collagen (Schnell et al., 2007) or covalent binding with ECM-derived peptides 
(Bockelmann et al., 2011, see below). Oliveira and coworkers seeded PCL conduits with 
mesenchymal stem cells and tested them for repair of median nerves in mice. Motor function after 
8 weeks was assessed with a grasping test in addition to histological examination. The study 
demonstrated good regeneration and a positive effect of the implanted cells (Oliveira et al., 2010). 
Poly(hydroxybutyric acid) 
In experiments with a PHB conduit, excellent results were achieved when the tube was filled with 
a GGF-containing gel (Mohanna et al., 2003, 2005). In a spinal cord implantation experiment, 
PHB constructs showed good integration and axonal regeneration within the graft (Novikova et 
al., 2008). These descriptions make clear that the best results were always obtained when polymer 
fibers were functionalized or combined with ECM proteins (Chap.I 4.3).  
4.2.3 Polyphosphoesters 
In addition to various aspects of biocompatibility, which they share with poly(a-hydroxy 
carboxylic acids), fibers of polyphosphoesters (PPE) offer the potential for coupling of bioactive 
molecules. PPE were therefore developed as matrices for PN implants (Wang et al., 2001). Films 
of electrospun fibers of poly(caprolactone-co-ethyl ethylene phosphate) (PCLEEP) served also as 
a delivery device for NGF (Chew et al., 2005) or GDNF (Chew et al., 2007). While it was 
possible to spin parallel aligned fibers of the PCL/PPE copolymer on a rotating drum, 
incorporation of the growth factor in the spinning solution made this difficult. When rolled films 
Figure 5 Evaluation of artificial nerve implants in animal experiments.  
(a–c) Electron microscopy of transverse sections: (a) non-lesioned sciatic nerve of the rat; (b) 
regeneration in an autologous nerve transplant; (c) regeneration in an implant with gradients of NGF 
and laminin after 4 months; distance 10 mm from the transection site; Ax axons, M myelin sheaths, Sc 
Schwann cell, scale bar 2 mm (Dodla and Bellamkonda, 2008). (d, e) Immuno-histochemical staining 
of longitudinal sections of regenerated axons in an implant with electrospun microfibers in rat sciatic 
nerve after 4 months: above neurofilament, axons; below S100, Schwann cells (Kim et al., 2008). (f) 
Retrograde tracing with FluoroGold from the distal end of a chitosan/PGA implant showing axonal 
regeneration of sensory neurons from the dorsal root ganglion in dogs at 6 months after implantation 
(Wang et al., 2005). (g) Electrophysiological recordings to assess functional regeneration cross a gap 
of 80 mm in dogs after 12 months. Collagen tubes with laminin-coated fibers were implanted into the 
peroneal nerve. Traces are shown for compound muscle action potential (CMAP) of the anterior 
tibialis muscle after stimulation of the sciatic nerve; motor evoked potentials (MEP) in the tibialis 
muscle after electrical stimulation of the motor cortex; somatosensory evoked potentials (SEP) 
recorded from the cerebral cortex after muscle stimulation; and spinal cord evoked potentials (SCEP) 
with stimulation of the nerve stump distal to the graft (Matsumoto et al., 2000). (h) Functional 
demonstration of regeneration (through the implants shown in d and e) in rats. In the grid walking 
test the number of mistakes are counted while the rat walks across a grid. Implants with fibers 
orientated in parallel (asterisk) achieved better results than implants without or with non-orientated 
fibers, yet autologous nerve transplants were still better (Kim et al., 2008). (i) The largest nerve gaps 
repaired with artificial implants, which showed recovery of motor functions, were found with dogs. 
Note movement of the left hind limb (Toba et al., 2001) 
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of fibers were tested as a 15 mm nerve bridge in rats, nerve regeneration was observed in all 
animals after 3 months, even without the growth factor. Electrophysiological examination showed 
a beneficial effect of the encapsulated growth factor (Chew et al., 2007). 
4.2.4 Poly(ethylene glycol) 
This polymer, which is non-adhesive to cells, is used to produce gels and matrices or serves as a 
linker for proteins. From poly(ethylene glycol), the star-shaped NCOpoly(ethylene glycol)-stat-
poly(propylene glycol) (sPEG) with a backbone of 80 % ethylene oxide and 20 % propylene 
oxide has been synthesized. A range of biochemical functionalities such as isocyanate, acrylate, 
and vinyl sulfone can be introduced to provide the basis for covalent modification. Using sPEG 
with reactive isocyanate end groups, blends of PCL and PCLdiol were functionalized with ECM 
derived peptides, which improved their properties as guidance substrates for axons and Schwann 
cells from DRG (Klinkhammer et al., 2010; Bockelmann et al., 2011). Recently, an easy method 
for peptide functionalization of polyester fibers via sPEG has been published, which is promising 
for in vivo applications (Grafahrend et al., 2011). 
4.2.5 Poly(2-hydroxyethyl methacrylate) and related hydrogels 
Synthetic hydrogels, a prime example being poly(2-hydroxyethyl methacrylate) (pHEMA), have a 
very high water content after polymerization. Gels consisting of poly(HEMA-co-methyl 
methacrylate) (pHEMA-MMA) implanted in the spinal cord of adult rats integrated well. Axonal 
regeneration into the implant was found by 8 weeks (Tsai et al., 2004). Hydrogels can be used to 
make scaffolds with structured channels or to encapsulate functional molecules when growth 
factors are added to pHEMA sheets during polymerization in aqueous solution. A nerve tube 
consisting of porous pHEMA-MMA was tested in 10 mm rat sciatic nerve gaps. After 8 weeks, 
the outcome was similar to autografts, and after 16 weeks 60 % of the artificial tubes were still 
comparable to this positive control (Belkas et al., 2005b). In an experimental medical application, 
pHEMA-MMA tubes filled with collagen resulting in a gel-like outer and porous inner structure. 
As implants in the adult rat sciatic nerve, such conduits were very successful over a period of 8 
weeks. In long-term survival studies, however, some of these implants tended to collapse and also 
evoked inflammatory reactions as suggested by the presence of macrophages and giant cells in the 
implants after 16 weeks (Belkas et al., 2005a). Copolymerization of HEMA with 2-aminoethyl 
methacrylate provided primary amine groups for covalent binding of laminin-derived 
oligopeptides. This approach was combined with physical modification of the gel, which 
contained multiple longitudinal channels (Yu and Shoichet, 2005). 
4.2.6 Oxidized polypyrrole 
The electrically conducting polymer poly(pyrrole) (PPy) is interesting for neural applications 
because electrical stimulation can influence axonal growth. In one study, electrospun PLGA fibers 
were coated with PPy, and electrical stimulation of the conducting nanofibers enhanced neurite 
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outgrowth (Lee et al., 2009). This work and related pioneering studies (Gomez and Schmidt, 
2007) were done with a PC12 cell line, however, this has only limited predictive value for 
neurons in vivo. While the material properties of PPy, which was discovered in the 1960s, have 
been thoroughly characterized, there is still limited experience with PPy as implant material in 
vivo (Schmidt et al., 1997; Wang et al., 2004; George et al., 2009). In a tube of combined PPy and 
silicone implanted to bridge a 10 mm gap in the rat, regeneration of nerve tissue was only 
marginally better than that in the plain silicone tube (Schmidt et al., 1997; Wang et al., 2004; 
George et al., 2009). Future studies will show whether the electrical conductance of PPy and other 
conducting polymers (polyaniline, polythiophene) is a real advantage in PN implants in vivo. 
4.3 Functionalization with ECM proteins and peptides 
As noted above (Chap.I 3.3), tubular implants and scaffolds with longitudinal pores have been 
made of collagen with very promising results. Similar success was obtained with artificial 
polymers that were blended or coated with collagen and laminin (Inada et al., 2004, 2007; 
Ichihara et al., 2009). On the other hand, synthetic polymers proved very useful in the 
construction of nerve guides, not least because of their superior physical properties. For instance, 
many hydrophobic polymers can be spun much more easily than ECM proteins (Klinkhammer et 
al., 2009). Unfortunately, they lack the specific biochemical functions involved in nerve 
regeneration (Chap.I 2.2 and 2.3). The purpose of functionalization is therefore to endow 
synthetic polymers with molecular moieties that activate endogenous cells (neurons, Schwann 
cells, endothelial cells) in a way that promotes axonal growth. Corresponding to the distinction 
between secreted and surface-bound signals, two fundamental approaches have been employed: 
binding of ECM molecules and controlled release of soluble growth factors. 
4.3.1 Blends of synthetic polymers with proteins 
The use of ECM molecules from the PNS is suggested because axons regenerate naturally along 
the basal lamina. Thus, ECM proteins or peptides are coupled to synthetic polymers either by 
blending, adsorption, or covalent binding (Koh et al., 2008) (Figure 6). This should promote cells 
to migrate into the artificial implant and close the gap between the nerve stumps. As discussed 
above, the main components of the basement membrane are the trimeric laminins plus collagen 
IV. Fibrous collagens (I, III, V) are major components of the ECM (Koopmans et al., 2009). 
Thus, a logical strategy was to blend synthetic polymers (e.g., of PLA with laminin (Koh et al., 
2008) or PCL with collagen (Zhang et al., 2005; Schnell et al., 2007)) and spin this material to 
fibers, which could then be used for the fabrication of tubular implants or guidance structures. 
PLA/laminin blends and PCL/collagen blends significantly improved the surface characteristics of 
electrospun nanofibers in comparison with the pure synthetic polymers. Some groups were able to 
spin fibers of pure ECM proteins (Chew et al., 2005; Heydarkhan-Hagvall et al., 2008); however, 
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some found it difficult to produce aligned fiber substrates of good quality with this method 
(Klinkhammer et al., 2009). 
4.3.2 Covalent functionalization of polymer fibers 
Instead of whole ECM proteins, which are extracted from biological sources, specific peptide 
sequences from laminin, fibronectin, or collagen can be synthesized (Wang et al., 2008; Dalton 
and Mey, 2009). Their design was made possible by the knowledge of specific amino acid 
Figure 6 Functionalization of polymer fibers for nerve regeneration. 
(a) Functionalization with adsorption or covalent binding of ECM molecules to electrospun polymer 
fibers (Koh et al., 2008). (b) Functionalization by blending of ECM molecules with synthetic polymers 
before electrospinning (Schnell et al., 2007). (c) Functionalization by chemical bulk modification of 
the electrospinning solution (Klinkhammer et al., 2010) 
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sequences in the ECM that bind to integrin receptors of Schwann cells and neurons. These 
peptides are adhesive because of the intracellular connection of integrins to the cytoskeleton. In 
addition, they activate a number of signal transduction cascades within the cells (Geiger et al., 
2001). So far, peptides with the amino acid sequences RGD, YIGSR, IKVAV, and longer 
versions of those have been successfully applied. People from my laboratory showed, for 
instance, that covalent binding of GRGDS to electrospun nanofibers of PCL improved their 
ability to guide axonal growth (Bockelmann et al., 2011). Several functionalization strategies with 
ECM molecules are also being tested in vivo: The interior surface of a chitosan tube was modified 
with various laminin peptides. As an artificial bridge of the rat sciatic nerve, the tube with one of 
these sequences promoted regeneration to a similar degree as a transplanted nerve, although not as 
well as autologous implants (Wang et al., 2008). In addition to ECM proteins, the cell adhesion 
molecules (CAMs, important examples for nerve regeneration are L1, N-CAM) constitute another 
group of surface-bound signals that can induce axonal growth. These transmembrane proteins, 
which are exposed on cell membranes and are not part of the ECM, are also being considered for 
functionalization (Webb et al., 2001). 
In conclusion, the chemical functionalization of synthetic materials with ECM molecules was an 
important step in the development of artificial implants with biological activities. Apart from 
these signals, which are always fixed to surfaces, peripheral nerve regeneration in vivo depends 
on a number of signals that are secreted from Schwann cells or the neurons themselves (Chap.I 
2.2).  
4.4 Controlled release of growth factors 
To apply soluble factors in vivo, the first ideas were to fill implanted devices with a solution of 
the growth factor or with growth-factor-secreting cells. In a more sophisticated manner, carriers 
are incorporated that gradually release the active molecules over longer periods. Several problems 
have yet to be solved (de Ruiter et al., 2009). For instance, the biological activity should be 
present for several weeks to months, especially in the case of longer nerve lesions. Also, 
sterilization should be possible without compromising the function of the signals. As these issues 
have been studied in several experiments, examples for the major paths of delivery are given 
below. The reader can find additional references in (Siemionow et al., 2010). 
4.4.1 Immobilization in the tubular wall 
A common feature of artificial nerve conduits is an outer wall in the form of a tube. Different 
techniques have been developed to immobilize growth factors such that they are released over 
time from the scaffold wall to the inside. In one study, tubes were fabricated by dip-molding from 
a solution of ethylene-vinyl acetate, bovine serum albumin, and FGF-2. In vitro assays revealed a 
burst phase of FGF release for the first 3 days (50 % of total protein), which then declined to a 
rate of 0.1 – 0.5 % per day. In vivo, after 4 weeks these tubes were clearly superior in bridging a 
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15 mm sciatic nerve gap compared to tubes without the growth factor (Aebischer et al., 1989). 
Madduri and coworkers incorporated NGF and GDNF in conduits consisting of collagen 
(Madduri et al., 2010a) or fibroin (silk) fibers (Madduri et al., 2010b). During biological 
degradation of the scaffold, the neurotrophic factors were gradually released. 
4.4.2 Growth factors released from gels 
Advanced conduit designs involve internal scaffolds for stabilization and guidance of the 
regenerating tissue. Hence, an obvious approach is to incorporate the growth factor into this 
polymer by mixing before gelling. This was done with NGF and NT-3 in pHEMA (Moore et al., 
2006). The growth factor can be equally distributed over the conduit or in the form a gradient to 
attract continued regeneration in the distal direction of the implant. In some cases, it could 
become a problem that axons are trapped within the chemoattractive environment of the conduit 
(“candy store phenomenon”). In a successful example of the gradient strategy, 40 mm gaps in the 
peroneal nerve of rabbits were bridged within little more than 6 weeks. This was achieved using 
PHB conduits filled with GGF (pro-neuregulin-1), which was suspended in alginate (Mohanna et 
al., 2005). Neither empty nor alginate-filled tubes without GGF were able to support growth of 
Schwann cells or axons across the complete gap, even after 9 weeks (Mohanna et al., 2003). 
Integration of polysaccharides into the polymer can enhance growth factor retention due to 
hydrophobic, electrostatic, or ionic interaction. This is a specific activation effect with heparan 
sulfate proteoglycans and growth factors FGF-2, VEGF, and GDNF (Barnett et al., 2002; Forsten-
Williams et al., 2008). This synergistic interaction was exploited by using alginate/heparin gels as 
a matrix for FGF-2, which increased vascularization and faster axonal growth through the 
artificial implants (Ohta et al., 2004). Combining growth factors with ECM proteins was also 
promising. Dodla and colleagues devised an agarose gel to apply gradients of NGF and laminin. 
Both gradients had a positive effect on nerve regeneration (Dodla and Bellamkonda, 2008). 
4.4.3 Microspheres as delivery vectors 
Instead of inducing growth factors into the conduit wall or the inner matrix, they can be 
encapsulated in microspheres before incorporation. With this approach, the release kinetics can be 
tested and tuned beforehand in vitro. Microspheres of PLGA and PLA with GDNF were 
embedded into the inner half of a PCL-tube fabricated by dip-coating. The microspheres were 
formed by adding an oil-in-oil emulsion of PLA and PLGA (the latter containing GDNF) drop-
wise to an aqueous solution, followed by centrifugation and lyophilization. The GDNF release 
kinetics observed in vitro showed a strong release of 4.6 ng GDNF per mg microsphere during the 
first day. The subsequent release approached zero-order kinetics and reached a cumulative release 
of 6.4 ng/mg microsphere at day 64. The bridging of a 15 mm rat sciatic nerve gap with this nerve 
conduit was much better than without the GDNF, similar to results obtained with nerve autografts 
(Kokai et al., 2011). In another study, nerve conduits containing PPE microspheres with NGF 
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were successfully used to bridge a 10 mm rat sciatic nerve gap. Three months after implantation, 
rats with NGF-microsphere conduits showed a higher percentage of positive reflex response than 
controls after pinching distal nerve trunks (Xu et al., 2003). 
4.4.4 Release from electrospun fibers 
Aligned electrospun fibers, which are perhaps the most promising topological cues for axon 
guidance, were also used to deliver growth factors. For example, PCLEEP fibers containing 
GDNF have been obtained by mixing GDNF into the polymer solution followed by 
electrospinning. The fibers were spun into a PCLEEP film, which was later rolled to form a tube 
on the inner surface of a nerve guide (Figure 2g). Release kinetics were characterized by an initial 
burst of about 30 % of protein followed by relatively stable release until leveling off after almost 
2 months. In vivo investigations with 15 mm rat PN lesions revealed a significantly higher 
number of myelinated axons inside the GDNF-implant compared to the controls (Chew et al., 
2007). Recently, a conduit was designed that consisted of a PLA-co-PCL shell made of 
electrospun nanofibers filled with an NGF-containing core of bovine serum albumin. Again, when 
tested as a sciatic nerve bridge of 10 mm in rats, results after 12 weeks were similar to those 
obtained with autografts (Liu et al., 2011). 
In summary many different and equally promising strategies of functionalization have been 
followed during the last decade (Figure 5 and Figure 6). Unfortunately, since there are hardly any 
studies that compare different strategies of functionalization, at this moment it is difficult to 
decide which molecules should be preferred in the future and which delivery strategy is most 
suitable. 
5 Conclusion 
In contrast to long-distance connections within the CNS such as the optic nerve or the white 
matter tracts of the spinal cord, lesioned peripheral nerves contain the inherent cellular and 
molecular components that are required to support successful axonal regeneration. The 
development of axon growth-promoting devices that incorporate a number of these components 
has become an expanding area of research. Although a number of biocompatible materials have 
been developed, which offer great potential for therapies of peripheral nerve injury, several 
technical or scientific challenges need to be addressed. 
5.1 Standardized control of efficiency 
Many experiments carried out using different biomaterials are not comparable with each other 
because different cell cultures, animal models, or criteria of success were used. In general, I have 
observed that a considerable number of publications reporting innovative materials failed to use 
appropriate biological tests. Papers falling into this category have not been discussed in the 
present review. Even in many animal studies, the inflammatory reactions, effects on gene 
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expression, and long-term results are rarely investigated. Clearly, a systematic approach with 
internationally agreed standards would be desirable for such investigations to allow a better 
degree of comparison. 
5.2 Structured three-dimensional implants 
So far, most studies of PN regeneration in vivo have only implanted hollow tubes, where axons 
start to grow on the inner surface of the implant. Thus a major technical challenge is the 
construction of three-dimensional nerve bridges with an internal architecture that is capable of 
guiding axonal growth and migration of the endogenous Schwann cells. In my opinion, the most 
promising approaches are the three-dimensional integration of microfibers in parallel orientation 
and the production of orientated channels in gels or matrices of ECM proteins. 
5.3 Biomimetic functionalization of implants 
With the use of proteins and peptides derived from ECM, artificial implants can already mimic 
the signals that regenerating axons encounter in the environment of the lesioned PNS. However, 
the concept of targeted use of factors that specifically activate Schwann cells, sensory neurons, or 
motor neurons is still in its infancy. In addition to the selection of the appropriate combination of 
molecular signals, the ideal temporal and spatial presentation of such molecules for the efficient 
support of axon regeneration and tissue repair remains unknown. In this context, it is possible that 
neurotrophic signals might be required for several months and with increasing gradients towards 
the distal end of the implant. 
5.4 The thirty millimeter mark 
Studies have demonstrated that peripheral nerve regeneration through artificial implants can cover 
distances of up to 30 mm but rarely beyond. Successful motor fiber regeneration appears to be 
more difficult than that of sensory axons, and thin fascicles regenerate more easily than large 
caliber nerves. Since larger gaps must occasionally be bridged in cases of human nerve injury, the 
usefulness of future constructs will be judged by their ability to support motor and sensory axon 
regeneration over long distances. For this, it is likely that experiments with animals larger than the 
rat will be required. I am convinced that results from basic research on mechanisms of axonal 
growth in combination with engineering methods (such as electrospinning, freeze-drying, and 
chemical functionalization) will result in further progress, with the development of artificial nerve 
implants that approach or even exceed the efficiency of the autograft. Some very substantial 
advances have already been made in the last few years. Thus, there is great hope and expectation 
that such strategies will provide the neurosurgeon with a range of cell-free scaffolds that can be 
used on demand. 
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Chapter II 
Manufacture and characterization of three-dimensional fiber arrays 
and assessment of guidance properties in vitro 
1 Introduction 
Peripheral nerve (PN) lesions can be surgically repaired by suturing the proximal and distal nerve 
stumps together. In these cases, axons regenerating from injured motor, sensory, and autonomic 
neurons are able to grow within the scaffolds of Schwann cells and extracellular matrix (ECM) of 
the injured nerve (Dalton and Mey, 2009). When PN injuries result in larger gaps between 
transected nerve ends, these have to be bridged, for instance, by transplanting a sensory nerve 
from the same patient. Unfortunately, this approach is functionally successful only in about half 
of the patients and has other disadvantages, such as sensory loss at the donor site and a limited 
availability of transplant material (Deumens et al., 2010). Currently, much research is therefore 
devoted to developing artificial nerve conduits that can replace autologous transplants (Deumens 
et al., 2010; Siemionow et al., 2010; Mey et al., 2012). 
For clinical use in humans, only simple tubular conduits have so far been approved in the United 
States and Europe (Siemionow et al., 2010). The majority of animal experiments are also based on 
the design of the hollow tube. Because axons grow on surfaces and must be guided toward their 
peripheral target, better results are expected if internal structures could support axonal growth and 
induce colonization with host-derived Schwann cells, which are required for trophic support and 
the subsequent remyelination of regenerated nerve fibers (Hoffman-Kim et al., 2010). Recent 
advances in the design of artificial nerve implants therefore focus on topographical features that 
guide axonal regeneration and cell migration. Basic design strategies for nerve bridges with 
internal guidance structures are based on (1) large interior channels to separate individual fiber 
fascicles (Clements et al., 2009; Yao et al., 2010), (2) scaffolds with many longitudinally 
orientated pores (Ceballos et al., 1999; Möllers et al., 2009), or (3) parallel aligned polymer fibers 
produced by melt extrusion (Matsumoto et al., 2000; Ribeiro-Resende et al., 2009) or 
electrospinning (Teo and Ramakrishna, 2006; Kim et al., 2008) (Figure 7).  
The approach presented here is based on electrospinning of the biodegradable polyester poly(ε-
caprolactone) (PCL) using two separated target electrodes, such that parallel fibers accumulate 
between them (Schnell et al., 2007; Klinkhammer et al., 2009). The resulting microfibers have 
been shown to be excellent growth substrates for glial cells and axons of sensory neurons 
(Gerardo-nava et al., 2009; Bockelmann et al., 2011). Given successful in vitro tests of several 
two-dimensional growth substrates a major challenge in scaffold design consists in the 
construction of three-dimensional (3D) structures that can be implanted in vivo. In this study, I 
describe a technique for 3D spinning of parallel microfibers, their embedding in collagen gels, 
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and incorporation in biodegradable PCL tubes. The biocompatibility of the resulting 3D scaffold 
was investigated using dorsal root ganglia (DRG) explants. 
2 Material and Methods 
2.1 Electrospinning of three-dimensional fiber arrays 
Solvents and PCL used for electrospinning were purchased from Sigma-Aldrich Chemie GmbH 
(Munich, Germany). Electrospinning was performed with 8 wt% and 12 wt% PCL (Mn = 70,000 –
 90,000 g/mol) dissolved in chloroform/methanol (3:1). Unless otherwise indicated, data are 
reported for fibers made from 12 % PCL. The spinneret consisted of a syringe with a 20G flat 
tipped needle connected to a metal disc with 90 mm diameter. After various target electrodes had 
been tested, the standard target configuration consisted of two opposing aluminum bars with a 
distance of 18 mm between them. These were mounted on a tapered base, which was connected 
with its narrow end to a grounded metal disc (Figure 8a). Of the different target devices, all made 
Figure 7 Conduit design for artificial nerve guides. 
(a) Empty tube used for bridging gaps between proximal and distal nerve stumps,used in 
most experiments so far; (b) tubular implant with multiple intraluminal channels (e.g. de 
Ruiter et al., 2008; Yao et al., 2010); (c) tube filled with an internal matrix structured by 
longitudinally oriented pores or channels (e.g. Bozkurt et al., 2012); (d) aligned polymer 
fibers as longitudinal guidance structures (e.g. Kim et al., 2008; Ribeiro-Resende et al., 
2009); (e) present construct consisting of 3D aligned PCL fibers embedded in layers of 
collagen gel. 
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of aluminum (Figure 8b–e), a stair case-like target was used for spinning of 3D fiber arrays 
(different sizes were successfully tested, e.g., 12 steps, 20 mm breadth, 1 mm step size; five steps, 
13 mm breadth, 1 mm step size; (Figure 8d,e and Figure 9a). Standard spinning conditions were 
17 kV, with 20 cm distance to the collector without mechanical ejection of the polymer solution 
by a syringe pump resulting in a feed rate of about 0.5 ml/h. However, depending on ambient 
conditions the distance between spinneret and target was adjusted between 17 and 20 cm to give 
Figure 8 Electrospinning setup for the collection of 3D fiber arrays. 
(a) Schematic diagram of the spinning device consisting of a syringe, 20 gauge needle 
connected with a metal plate (spinneret), high volt- age power supply, and grounded 
collection target, which is mounted on a conducting v-shaped base likewise connected to a 
metal plate. (b–e) Photos of different target designs to illustrate accumulation of parallel 
fibers. Two parallel bars (b) resulted in a single layer of paral- lel fibers accumulating on the 
upper edge. Substituting edged bars with a curvature allowed (c) accumulation on a slightly 
wider depth on the target. The best target for 3D-spinning is characterized by a stepped 
design (d) resulting in a sequential accumulation of fibers from bottom to the top edge (e, 
arrows). 
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Figure 9 Three-dimensional arrays 
of parallel fibers. 
(a) Electrospun fibers suspended in a 
step target are shown from the side. (b) 
Projection of a 400-mm confocal scan 
from above demonstrates the parallel 
alignment of the fibers. (c) SEM image 
of fibers with 200-fold and 5000-fold 
magnification. High magnification 
photos were used to determine the 
fiber diameters (fiber seen as a vertical 
line in the inset; 808 ± 175 nm, 
mean ± SD) 
best results. For spinning of one batch of fibers I applied the voltage for approximately 30 s to the 
spinneret. To handle the three-dimensional array of fibers after spinning, the bars were attached to 
a U-shaped frame before disassembling it from the base. To visualize electrospun fibers with 
fluorescence microscopy, the lipophilic dye DiI [Molecular Probes, D3911, 75 ml DiI/DMSO 
(1/1000) in 20 ml] was added to the PCL solution. 
2.2 Physical characterization of fiber arrays 
Electrospun fibers suspended on the targets were examined with a Leica TCS SP2 confocal 
microscope (Leica Microsystems GmbH, Wetzlar, Germany). For documentation of alignment 
and density of the fiber arrays image stacks were produced from the upper most fiber plane 
reaching 2 mm down into the lowest fiber plane. The image stacks were processed for further 
analysis using Image J software. For evaluation of fiber density, I divided a stack into five bins of 
400 µm, made a projection of all images in one bin and counted the number of fibers crossing the 
midline. For assessing fiber alignment, the mean direction of all fibers in a stack was determined 
and the deviation angles of the individual fibers were plotted. The standard deviation (SD) of 
deviation angles was calculated using MATLAB. Fiber diameter was determined by sputter 
coating the samples with 30 nm gold and 
performing scanning electron microscopy 
using a FEI/Philips XL30 FEG ESEM 
with a 10 kV electron beam. Using high 
magnification (5000×) images of single 
fibers I averaged the thickness of each 
fiber from five positions within an image. 
Mean fiber thickness and standard error 
(SEM) were calculated from 23 fibers of 
five different samples. 
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2.3 Inserting the 3D fiber arrays into a conduit 
For biological testing, the electrospun fibers were inserted in gels that consisted of type I 
collagen. For the matrix, I prepared a 2.4 mg/ml solution of rat tail collagen I (Life Technologies, 
A1048301) according to the manufacturer’s protocol. In brief, one part 10× basal medium Eagle 
was added to eight parts rat tail collagen I solution. I neutralized the pH with 1 M NaOH and then 
filled up to 10 parts with distilled water (DRG cultures) or with cell suspension to obtain 
10
6
 cells/ml. To prevent premature gelation, the collagen solution was kept on ice during the 
whole procedure. To produce composites of collagen and PCL fibers, a drop of 50 ml collagen 
solution was applied onto a poly-L-lysine coated cover slip. Using a U-shaped frame to hold the 
target electrodes the fiber array was deposited into the collagen solution and detached from the 
frame using hot forceps. To induce gelation, the composites were placed in an incubator for 30 –
40 min at 37°C and 95 % humidity. This step could be repeated several times to incorporate 
additional layers of fibers. 
For manufacturing implantable tubes to be filled with the composite of gel and fibers, porous, 
biodegradable PCL tubes were made by dip coating. Crystalline NaCl was ground to fine powder 
in a mortar and was mixed with an equal amount (wt) of a 12 % PCL-solution in 
chloroform/methanol (3:1). Steel wires of 2 mm diameter were repeatedly dipped into the 
NaCl/PCL suspension to produce conduits of 1 – 2 cm length and 500 µm wall thickness (for a 
final construct of 1.5 cm). The surface was leveled after 1 min drying at RT. After another 5 h of 
drying, the conduits were removed from the wires and transferred to a Petri dish with stirred 
deionized water for 24 h to dissolve the NaCl(Chang, 2009). Water was changed twice. Conduits 
were cut lengthwise in half and filled with gel/fiber stacks as described above for glass cover 
slips. Subsequently, half-tubes were resealed using the PCL solution and equilibrated with cell 
culture medium. All steps were performed under sterile conditions. The thickness of the tube wall 
was determined with scanning electron microscopy. 
2.4 Cell and organ culture 
All cell culture reagents were purchased from Life Technologies GmbH (Darmstadt, Germany). 
Before the experiments, astrocytoma cells (U373) were grown in Dulbecco’s modified Eagle 
medium (DMEM) with Glutamax and enriched with 10 % fetal calf serum (FCS) and 0.2 % 
penicillin/streptomycin at 37°C, 5 % CO2. The culture medium was changed every second day 
and cultures were split twice a week. For the experiments, cells were washed with phosphate 
buffered saline (PBS) and detached from the surface of the culture flask using 0.25 % 
trypsin/ethylenediaminetetraacetic acid (EDTA). After trypsination was stopped by adding 5 ml 
serum containing medium, cells were centrifuged and resuspended in culture medium. Cell 
numbers were determined using a Thoma chamber. 
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For organ cultures, I dissected DRG from 10-day-old chicken embryos. The embryos were 
decapitated and the skin removed. Accessing from the dorsal side, sharp forceps were inserted 
close to the lumbar vertebral column. By opening the forceps the hind limb could then be 
separated from the torso. The DRG, remaining on the inside of the thigh, were removed and 
collected in cold, sterile PBS, where they were kept until being transferred to the collagen matrix 
(< 30 min) and before adding of the PCL-fibers. After gel formation, the samples were placed in a 
24-well plate with 1 ml culture medium and incubated at 37°C and 5 % CO2 for six (single cells) 
or seven days (DRG). The medium was changed once after three days. 
The biological compatibility of the complete conduits was also tested with DRG cultures. After 
coating the inner side of the longitudinally sectioned half-conduits with poly-L-lysine, several 
layers of collagen and PCL-fibers were added together with a DRG explant. To allow microscopic 
evaluation, I sealed the surface with a poly-L-lysine coated cover slip and transferred the 
assembly upside down to a culture well, where culture media could only enter through the wall or 
the endings of the conduit. After 30 min gelation at 37°C I added 1 ml of culture medium to the 
well. The culture was maintained for seven days with medium change once after three days in 
vitro. Axonal growth and cell migration was investigated in whole mounts. 
2.5 Immunocytochemistry 
Samples were fixed 1 h with cold 4 % paraformaldehyde/phosphate buffer, rinsed with PBS and 
blocked with 1 % bovine serum albumin, 4 % normal goat serum and 0.1 % TritonX-100 in PBS 
for 1 h. Incubation with the primary antibody [either 1/500 rabbit-anti-S100 (Sigma-Aldrich, 
Munich, Germany, S2644) or 1/500 rabbit-anti-NF200 (Sigma-Aldrich, N4142)] was performed 
over night at 4°C in blocking solution. Incubation with secondary antibody, Alexa Fluor 488 goat-
anti-rabbit (Life Technologies GmbH, Darmstadt, Germany, A11008), 1/500 in blocking solution, 
was done for 1 h at room temperature followed by nuclear staining with 4’,6-diamidino-2-
phenylindole (DAPI, 1:5000) for 10 min. Negative controls were performed without primary 
antibodies. Samples were placed upside down on object slides using Fluoprep (Biomerieux) to 
stabilize fluorochromes. 
2.6 Fluorescence microscopy 
Images of the U373 astrocytoma cell cultures were captured using a Leica TCS SP2 confocal 
microscope and were further processed using Image J software. Cell migration and axonal 
outgrowth from DRG were analyzed with a Leica DM5000B epifluorescence microscope using 
filter cubes L5, N2.1 and A4 for Alexa Fluor 488, DiI and DAPI nuclear staining. Photos were 
recorded with a Leica DFC350 FX digital camera. Composite pictures of entire DRG and all 
outgrowing cells and axons were assembled by means of a Leica DMI6000 microscope with 
LASAF software. Individual cells and their interaction with PCL fibers were imaged using Leica 
TCS-SP5 confocal microscopy and further processed using Image J. 
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2.7 Quantification of Schwann cell migration and axonal growth 
On composite photographs of DRG four tangents were drawn to the edges of the DRG in parallel 
and orthogonal to the fiber direction or, in case of the controls, horizontal and vertical with 
respect to the photographic frame. For cell migration, I measured the distance between the farthest 
cell body and the corresponding tangent. For axonal outgrowth, I counted the number of visible 
axonal endings and measured the distance between the 10 % longest axons and the corresponding 
tangent. In the statistical analysis the individual DRG were considered as independent samples. 
Conditions were compared using Student’s t-test, calculated with MATLAB. 
3 Results 
3.1 Electrospinning of parallel fibers in a 3D configuration 
The configuration of the fiber array produced with electrospinning depends on the geometry of 
the target which is used. Although a simple plate target results in a mat of non-oriented fibers, 
parallel fiber alignment can be obtained with targets consisting of a rotating drum or two parallel 
bars. Using the latter design, I collected PCL fibers that were suspended in the air between the 
two target bars (Figure 8a). Fibers were aligned in parallel but formed one layer as they attached 
to the upper edge of the bars (Figure 8b). To achieve a 3D array of the accumulating fibers, 
various target configurations were tested by modifying the bars. For instance, replacing the sharp 
edges with a rounder curvature led to the accumulation of fibers on a slightly wider area of the 
target, yet the distribution was not easy to control and was frequently different between the left 
and right bar (Figure 8c). Taking advantage of the fact that the fibers tend to accumulate on edges, 
where electric field lines converge, I designed step-like targets with multiple edges facing each 
other (Figure 8d). On this kind of target, the accumulation of fibers starts at the lowest edges. 
With increasing density as fibers accumulate on these edges, electrostatic repulsion between them 
forced further fiber accumulation towards the next higher steps. In this way, a consecutive 
accumulation of fibers from bottom to top was achieved (Figure 8e) resulting in a 3D 
configuration of PCL fibers. A view from the side of a 3D fiber array spun onto the final version 
of the target is shown in Figure 9a. Microscopic evaluation of fluorescently labeled fibers (Figure 
9b) and SEM visualization (Figure 9c) demonstrated the degree of their alignment.  
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Figure 10 Quantitative characterization of 
the 3D fiber array. 
(a) Fiber density was determined from 
sequential confocal scans of 400 mm thickness 
through the fiber arrays suspended in the target 
frame (mean ± SEM, n = 3 targets). The fiber 
density decreases from top to bottom with the 
bottom layer still containing more than 
18 fibers/mm2. (b) The histogram depicts 
variability of fiber orientation as individual 
deviation from the mean orientation (n = 559 
fibers from six samples. Angular standard 
deviation is 2.46°). 
3.2 Characterization of electrospun 3D PCL-fiber arrays 
To quantitatively characterize the fiber arrays, the fiber density at different depths inside the array 
was binned (bin 1 to 5; Figure 10a). The fiber density decreased from the top to the bottom of the 
3D array, with the highest and lowest fiber density, 86.7 ± 5.1 fibers/mm
2
 (area of cross section, n 
= 5 fiber stacks, mean ± SEM) and 18.3 ± 6.4 fibers/mm
2 
in the first and last bin, respectively 
(ANOVA p < 0.005; F = 8.00; df = 4). The mean fiber density was 48.8 ± 4.5 fibers/mm
2
.  
To assess fiber alignment, I determined the direction of the individual fibers, calculated the mean 
orientation of all fibers and for every fiber its deviation angle from the mean orientation (Figure 
10b). The alignment of electrospun fibers was high, as fiber angles showed a narrow Gaussian 
distribution with around 70 % of the fibers deviating less than 2.5° from the mean fiber 
orientation (n = 559 fibers; SD = 2.46°). Only about 1 % of all measured fibers deviated more 
than 10° from the mean. The maximum deviation was 15°. 
Fiber diameters were determined on the basis of scanning electron microscopy photos (Figure 9c). 
As described previously (Jha et al., 2011), fiber diameter was dependent on the PCL 
concentration of the spinning solution used. A concentration of 8 % PCL resulted in a fiber 
diameter of 660 ± 190 nm (mean ± SEM). By raising the concentration to 12 %, the fiber diameter 
was increased to 808 ± 175 nm (p < 0.05; compared by student’s t-test). 
3.3 Suspension and manipulation of 3D fiber 
arrays in biocompatible gels 
The 3D arrays of PCL fibers were embedded into a 
collagen matrix by inserting the fibers into the gel 
(Figure 11a). To handle the 3D fiber stacks for this 
purpose, electrodes were fixed to a metal frame 
(Figure 11b) and detached from the spinning setup 
with the suspended fibers between them. The 
embedding caused some compression of the array 
thereby increasing the fiber density. 
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To achieve larger 3D stacks that were not limited by the size of the electrospinning targets, this 
procedure could be repeated several times by stacking alternate layers of fiber arrays (Figure 11c–
e). The thickness of the gel layers between 3D fiber arrays was determined by the viscosity of the 
gel solution. To reduce displacement of the fibers by the collagen solution it was important to 
introduce them before gelation of the collagen took place. Gelation was initiated by heating the 
collagen to 37°C, but to some extent changes in viscosity of the collagen already occurred at room 
Figure 11 Embedding of 3D fiber stacks in collagen. 
(a) Schematic drawing of the embedding process. The collagen solution is applied onto a 
poly(lysine)-coated coverslip. Subsequently, fibers are dipped into the collagen solution and 
detached from the frame using hot forceps. Gelling was induced by incubation of the 
composite at 37 C for 30 min. To add fiber layers, the process was repeated several times. 
(b) For handling of the fiber stacks a U-shaped frame was used to keep the two parts of the 
target in place when detached from the base. (c–e) Arrangement of fiber stacks in the 
collagen gel shown in cross section after one (c), two (d), and 10 (e) rounds of deposition. (f) 
One single 3D array of PCL fibers was maintained in a gelatin gel which was cast over the 
fibers suspended between the target electrodes. 
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temperature. Thus with collagen gels I obtained a matrix with several 3D arrays of fibers 
separated by regions devoid of fibers (Figure 11d and Figure 7e). A standard array now consists 
of 10 layers of fibers and gels with a distance of 70 – 120 µm between the layers (Figure 11e)]. 
An alternative method to contain the 3D fiber array within a hydrogel consisted in casting the gel 
solution over the fibers (Figure 11f)]. 
The effect of fiber-containing collagen matrices on cell shape was first tested using the glial cell 
line U373. These cells grew well within the scaffolds and produced cellular processes. When the 
cells were cultivated inside the 3D collagen matrix without PCL fibers, I observed a more diverse 
morphology than in 2D cultures. In the 3D gels, many cells had complex cell bodies with several 
processes in various directions (Figure 12a). When PCL fibers were added in 2D or 3D cultures 
cell bodies tended to attach to the polymer fibers (Figure 12b). In 3D collagen matrices, all cells 
Figure 12 Gel-embedded PCL fibers affect cell morphology.  
To visual- ize the effects on cell shapes U373 cells were cultivated for 6 days in a 3D 
collagen matrix with and without PCL fibers. (a,b) Confocal microscopy images show 
immunostaining against S100 (green) and nuclear staining (DAPI, blue). PCL fibers were 
stained red using DiI. Panels (a) and (c) show cell morphologies in the absence of PCL 
fibers, panels (b) and (d) with PCL fibers in the gel. Different magnifi- cation are shown in 
(a) and (b) with all scale bars measuring 50 mm. (c,d) Reconstructions of cells from both 
conditions to display the dif- ferent cellular morphology in space. The red arrow in (d) 
points at the PCL fiber. 
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which made contact with PCL fibers produced only two processes pointing in opposing directions 
along the path of the PCL fiber. Additional processes could only be observed when cells had 
contact with more than one fiber. Despite their ability to grow in complex shapes within the 3D 
collagen gels (Figure 12c) the presence of PCL fibers imposed a fusiform morphology on the cells 
(Figure 12d).  
3.4 Influence of PCL fibers on axonal growth 
To assess the influence of the 3D gel/fiber substrates on Schwann cells and sensory neurons, DRG 
were explanted on the gels, and axonal growth and glial cell migration were quantified. 
Representative images of DRG cultures in collagen gels with and without PCL-fibers are shown 
in Figure 13. The 3D gel/fiber matrices caused a directional outgrowth of axons (Figure 13a) and 
a preference in the direction of cell migration (Figure 13b). 
When comparing the total number of axonal endings I found no significant difference between the 
two conditions. Although initial neurite outgrowth was not influenced by the PCL fibers, this was 
the case for axonal elongation. Under control conditions, when no fibers were contained in the 
gel, the statistical analysis revealed no preference of axonal growth in any direction (Figure 13a) 
and Figure 14a). At 4 DIV and 7 DIV the ratio of axon length in two orthogonal directions of the 
Figure 13 Gel-embedded PCL fibers as a guidance structure for Schwann cells and 
sensory neurons. 
Dorsal root ganglia were cultivated for 4 and 7 days in a 3D collagen matrix with and 
without PCL fibers as control. Axons were immunostained against NF200 (a) and nuclei 
were stained with DAPI (b). Yellow arrows indicate the orientation of PCL fibers in the 
samples. 
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image was close to one (Figure 14b). In contrast, collagen gels that contained aligned PCL-fibers 
had the effect that axons in direction of the PCL fibers were significantly longer than in the 
absence of fibers, and axons in the direction orthogonal to the PCL fibers were significantly 
shorter (Figure 14a), t-test p < 0.01 at 4 DIV]. For instance, after 4 DIV mean axon lengths in 
parallel with PCL fibers was 1148 ± 81 µm, whereas in the orthogonal direction they only reached 
378 ± 36 µm. 
As axonal growth along the electrospun fibers continued in the cultures, the difference between 
the two directions was even larger at 7 DIV. Axons also continued to grow in collagen gels 
without PCL fibers. For this reason the difference in axon length between gels without PCL fibers 
and the preferred direction in the collagen/PCL fiber matrix was no longer significant. However, 
the orientation index demonstrated quantitatively that the fiber containing matrices continued to 
Figure 14 Quantification of the guidance properties of gel-embedded PCL fibres. 
(a) Axon length in different directions is plotted as a result of the different 3D substrates. 
Data show mean of the 10 % longest axons of every explant. Substrates were collagen gels 
without or with PCL fibers. For the controls axonal growth was analyzed in arbitrarily 
defined horizontal and vertical (h and v) directions; for fiber containing gels axon lengths 
was assessed in parallel and orthogonal to the fiber direction (p and o). (b) An orientation 
index for axon length was determined as the ratio between the two directions measured for 
every condition (h/v or p/o). (c) The distance of cell migration from the DRG was quantified 
in a similar manner, and (d) an orientation index was calculated accordingly. Asterisks 
indicate significant differences between the PCL fiber sample and control; pound symbols 
indicate differences between the two directions within PCL fiber samples. Bars show 
mean ± SEM (n ≥ 6 DRG explants; Student’s t-test; p* < 0.05; p*** < 0.001; p### < 0.001). 
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exert a strong guidance effect on the growing axons, whereas outgrowth was random in isotropic 
collagen gels (Figure 14b). Comparing the results at both time points indicated that under all 
conditions axonal elongation slowed down during the time course of cultivation. 
3.5 Influence of PCL fibers on glial cell migration 
The data for cell migration demonstrated a similar effect of the aligned PCL fibers (Figure 13b 
and Figure 14c,d). Under the control condition of 3D gels without fibers there was no significant 
difference in the distance of cells that migrated from the DRG in vertical or horizontal direction 
(e.g., 4 DIV: 834 ± 52 µm vs. 780 ± 60 µm). When cultivated in the presence of aligned PCL-
fibers, cell migration parallel to the fiber orientation reached significantly longer distances (e.g., 
at 4 DIV: 1509 ± 55 µm) in comparison with cell migration perpendicular to the PCL fibers 
(4 DIV, 7 DIV: both p < 0.001) and also in comparison with cell migration in 3D gels without 
fibers (4 DIV: p < 0.05; 7 DIV: p < 0.001). As for axonal growth the orientation index was highly 
significant at 4 DIV and 7 DIV (Figure 14d). 
3.6 Incorporation of gel/fiber composites in a tubular conduit 
To use the gel/fiber composite scaffold as a substrate for PN regeneration I inserted it into a PCL-
conduit, which was manufactured by dip-coating a steel rod with PCL solution. The addition of 
NaCl to the PCL-solution and subsequent leaching resulted in the formation of a tubular conduit 
wall with a porous surface (Figure 15). It also increased the flexibility of the conduit and hence 
the suitability for in vivo applications. Surfaces and cross sections of tubes were examined with 
scanning electron microscopy (Figure 15a,b), and parameters of the dipping technique 
(concentration of the solutions, repetitions of coating) were adjusted according to the results. 
PCL tubes were longitudinally cut in half, gel/fiber scaffolds were inserted into the half tubes, and 
artificial nerve bridges were then produced by sealing two half tubes with PCL-solution (Figure 
15c). To investigate the biocompatibility of the constructs, DRG explants were cultivated inside 
the half conduits, which were sealed with a cover slip, so that exchange of metabolic matter could 
only occur through the gel and PCL wall or via the endings of the conduit. The cultivated DRG 
showed no visible change in appearance compared with those cultivated in open 3D gels. After 
7 DIV, axon growth and cell migration had occurred within the 3D matrix (Figure 15d) and on the 
surface of the cover slips. Anti-NF200 immunohistochemistry revealed widespread axonal growth 
and similar axon lengths to those observed in 3D cultures that were not enclosed by tubular 
conduits. Nuclear DAPI staining of cells that had migrated out of the DRG indicated cell 
migration was also not impaired. 
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4 Discussion 
To develop artificial scaffolds for PN regeneration I have described a method for the 3D assembly 
of electrospun PCL fibers in parallel alignment. Consecutive embedding of these fibers in layers 
of collagen gels and incorporation in a tubular conduit resulted in a 3D scaffold for axonal 
guidance, whose biological use was tested with DRG explants. Schwann cells and sensory axons 
adhered to the PCL fiber substrate and were guided by the orientated structure inside the gel/fiber 
scaffold. Within the 3D collagen gels contact with the microfibers caused the cells to assume a 
spindle-shaped morphology following the fiber direction. 
Previous developments of fiber substrates revealed two major challenges with respect to the goal 
of an artificial nerve implant, (1) the incorporation of microfibers in a 3D configuration, and (2) 
the functionalization of the growth substrate to attract axonal growth over long distances 
Figure 15 Integration of the composit scaffold into a biocompatible conduit. 
Conduits were produced from a mixture of a 12 % PCL solution and NaCl by dipmolding and 
subsequent leaching of the NaCl fraction. (a,b) SEM images depict the porous structure of 
the conduits wall (cross-section in a) and surface (b). (c) Scheme of the culture model used 
to verify biocompatibility of the conduit. In the inset a photograph of the collagen-fiber 
scaffold integrated into the tubular PCL conduit is shown. (d) Axonal growth and cell 
migration occurred within the structured 3D conduit. Axons are marked with NF200 
immunostaining, migrated cells with nuclear DAPI stain. 
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(Bockelmann et al., 2011). The present study contributes to solving the first of these problems and 
provides a 3D platform to address the second. 
4.1 Three-dimensional configuration of guidance structures 
Artificial nerve bridges are designed as tubular grafts that connect the proximal with the distal PN 
stump (Siemionow et al., 2010; Mey et al., 2012). When hollow cylinders with a single lumen are 
used, regenerating axons and migrating cells accumulate on the inside of the tubular walls. 
Constructs with several lumens were fabricated to increase that surface area and to separate 
different fiber bundles within the conduit (de Ruiter et al., 2008; Clements et al., 2009; Yao et al., 
2010). However, increasing the number of compartments with these methods, for example by 
using seven channels or by incorporating three films, did not improve regeneration (Clements et 
al., 2009; Yao et al., 2010). Although implants have also been developed that were filled with 
non-orientated “isotropic” matrices (Labrador et al., 1998; Toba et al., 2001; Inada et al., 2004; 
McGrath et al., 2010), most studies indicate that orientated 3D structures with a large surface area 
are required to provide an adequate substrate for long distance axonal guidance (Hoffman-Kim et 
al., 2010; Mey et al., 2012). I can distinguish two basic designs that provide such internal 
guidance structures within tubular implants (Figure 7). The tubes contain either longitudinal fibers 
or a porous matrix with longitudinal orientation of the pores. Conduits that consist of polymer 
fibers can be produced by a number of different techniques such as drawing from a melt, template 
synthesis, phase separation, self-assembly and electrospinning (Teo and Ramakrishna, 2006; 
Schnell et al., 2007; Kim et al., 2008). A major challenge consists in filling the conduit with the 
orientated fibers. 
One strategy consists of stacking 2D films of parallel fibers above one another. In one previous 
study, this was done with 10 – 12 films of electrospun poly(acrylonitrile-comethylacrylate) fibers 
inside longitudinally split polysulfone tubes, which were then sealed and implanted to bridge 
17 mm sciatic nerve gaps in rats (Kim et al., 2008). More recently, an improved method for 
manufacturing 3D fiber scaffolds was published (Yang et al., 2011). Highly aligned parallel fibers 
were electrospun onto individual non-conductive frames using a conductive wire as target. The 
holding frames with suspended microfibers were then placed across the surface of a hydrogel, 
covered with a spacer frame and another layer of hydrogel was added. This process was repeated 
several times to create a 3D microfiber scaffold (Yang et al., 2011). The procedure explained in 
the present study is based on the 3D accumulation of fibers already during the spinning process. 
This could be used also for successive stacking of fiber and gel layers (Figure 11d,e) or for 
casting a gel over the 3D fiber array (Figure 11f). 
While I modified the physical design of the target electrode to achieve a 3D fiber configuration, a 
similar technique of “air gap electrospinning” also used two horizontally separated targets, each 
connected to a common voltage with respect to the spinneret (Jha et al., 2011). To manufacture an 
Chapter II 
56 
 
implantable scaffold, an exterior coating of poly(glycolic acid)/poly(lactic acid) copolymer was in 
this case deposited onto the outside of the cylindrical fiber configuration. For this, a circular steel 
plate was placed behind the fibers, and the spinneret was used for subsequent electrospraying of 
the copolymer (Jha et al., 2011). A different technique was developed by Schlosshauer’s group, 
who produced oriented PCL filaments by hot melt extrusion through nozzles with six-leaf cross 
sections. After extrusion, the filaments were drawn in a separate process. This resulted in yarns of 
several hundred filaments, each with six longitudinal grooves, which could be inserted in a 
tubular conduit (Ribeiro-Resende et al., 2009). These structured filaments have been 
functionalized in various ways including siRNA (Hoffmann et al., 2011) and were successfully 
used to fill epineurial tubes in vivo (Hajosch et al., 2010). Using the method of injection molding 
chitosan conduits were produced that contained several hundreds of longitudinally aligned PLGA 
fibers (Wang et al., 2005; Ding et al., 2010). 
The second approach to achieve internally structured implants aims at scaffolds with longitudinal 
pores or channels. One method to achieve this is the application of strong magnetic fields which 
orient collagen or fibrin matrices (Ceballos et al., 1999; Dubey et al., 1999; Verdú et al., 2002). 
Another promising technique consists in the controlled freeze drying of collagen suspensions. 
When the solvent is caused to freeze from one side of the solution, collagen is displaced, thus 
resulting in collagen walls of longitudinally orientated guidance channels. The diameter of these 
pores can be controlled to be in the range of 20 – 120 µm (Bozkurt et al., 2007, 2009; Möllers et 
al., 2009). Structured collagen conduits, which are commercially available (Perimaix, Matricel 
GmbH), were implanted as sciatic nerve grafts in rats, and axonal regeneration followed the 
longitudinal pores of the artificial nerve guide. In these experiments better outcomes were 
achieved by co-implanting Schwann cells (Bozkurt et al., 2012), though fiber containing implants 
appear to achieve similar or better results without the need to implant live cells (Wang et al., 
2005; Hu et al., 2013). 
4.2 Biological functionalization of the growth substrate 
Although pure polymer fibers, such as PCL or poly(lactic acid), already proved useful as guidance 
structures, several studies showed that functionalization either by covalent binding of ECM 
peptides (Bockelmann et al., 2011) or blending with ECM proteins (Schnell et al., 2007) 
improved the ability of such fibers to guide cell migration and axonal growth. In the present 
experiments the surrounding gel already consisted of collagen with signal sequences that can 
activate cellular integrin receptors. With the use of hydrogels that contain signaling molecules one 
might therefore use artificial polymer fibers without the further need of functionalization. I found 
that axonal growth along non-functionalized PCL fibers in a 3D collagen environment was 
initially faster than in pure collagen, however, with time, that is after 1 week, this difference 
disappeared. Possibly, activation of axonal integrin receptors by the collagen supported axonal 
5 Conclusion 
57 
 
elongation whereas no such signaling was initiated by the PCL. This outcome suggests that 
additional modification of the fibers with signaling molecules may be beneficial. 
Coating of artificial polymer fibers with laminin or fibronectin enabled axons to grow faster than 
the migration of Schwann cells (Hoffman-Kim et al., 2010). An easy technique to achieve such 
functionalization consists of blending a synthetic polymer with fibronectin, collagen or laminin 
when preparing the electrospinning solution. Cell culture investigations demonstrated this 
approach to be even superior, with respect to certain aspects, to more sophisticated chemical 
modification (Koh et al., 2008). Recently, an innovative method for the synthesis of covalently 
functionalized poly(D,L-lactide-coglycolide) fibers has been published. The polyester was made 
hydrophilic by adding star-shaped poly(ethylene oxide) followed by covalent binding of cell-
adhesion mediating peptides. The resulting fiber matrix was bioactive and promoted cell adhesion 
via recognition of the immobilized binding motifs (Grafahrend et al., 2011). For functionalization 
through blending or covalent modification in the electrospinning solution the present 3D spinning 
setup with staircase-like targets can be used without further modifications. 
When, as here, electrospun fibers are embedded in a biocompatible hydrogel, the preferential 
adherence of axons to the electrospun fibers is an issue. In previous 2D studies aligned fibers 
were placed on non-treated tissue culture plastic (Kim et al., 2008) or on cell repellent substrates 
(Schnell et al., 2007; Klinkhammer et al., 2009), which left the cells little choice but to attach to 
the fiber substrate. In 3D composites that consist of guidance fibers suspended in a supportive 
matrix a suitable balance of cell surface attachment between the different material components 
must be struck. With the imbedding of pure PCL fibers in a collagen gel the guidance effect or the 
morphological alignment was maintained. It remains to be seen whether this remains when 
additional growth promoting factors, for example neurotrophins, are introduced into the matrix 
(Dalton and Mey, 2009). Different combinations of gels and modification of artificial polymers 
can now be tested. 
5 Conclusion 
I report a technique for the 3D electrospinning of parallel microfibers that were suspended in 
collagen gels and incorporated in a tubular nerve implant. In contrast to conventional hollow 
nerve conduits, this nerve guide with aligned arrays of anisotropic fibers directed axonal 
regeneration and Schwann cell migration in the longitudinal axis of the scaffold. The comparative 
advantage of this design in comparison with alternative designs will now be tested in vivo. 
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Chapter III 
Assembly of artificial nerve implants and assessment of their 
suitability to support nerve regeneration in vivo 
1 Introduction 
Traumatic injuries are frequently accompanied by damage to a peripheral nerve (PN). A complete 
nerve transection considerably prolongs the dysfunction of an affected body part far beyond the 
damage to bones or muscular tissue and hence impairs the patient’s autonomy, even when most of 
the injured tissue has already been restored. As a result, it can aggravate the patient’s emotional 
distress and produce relevant social and economic costs (Rosberg et al., 2005). Despite these 
serious consequences, options for clinical treatment of PN injuries are limited (Lundborg, 2000; 
Deumens et al., 2010). Since an end-to-end suture is only possible when the two stumps can be 
brought together in a tensionless manner, the first choice for treating a PN gap is the insertion of 
an autologous nerve graft (Meek and Coert, 2014). However, this approach implicates donor site 
morbidity and may cause other complications associated with the necessity of a second operation. 
For short nerve gaps it is possible to bridge the two stumps with saline-filled but otherwise empty 
tubes of biodegradable materials. These are the only artificial nerve bridges that are clinically 
approved at the moment (Meek and Coert, 2014). Their use circumvents the drawbacks of 
autologous nerve transplants, however at the cost of a generally reduced prospect of regeneration, 
and the disadvantage increases with the size of the gap (Isaacs, 2010; Konofaos and Ver Halen, 
2013). Intensive research is therefore being carried out to develop new scaffold designs and 
materials that allow functional recovery after PN injury (Mey et al., 2012; Jager et al., 2014).  
The reduced efficacy of conventional hollow nerve conduits is attributed to the lack of supportive 
cues, which are present in the distal nerve stump or in an autologous nerve graft (Meek and Coert, 
2014). These include endogenous trophic factors acting on regenerating axons, including 
neurotrophins, glial cell-derived neurotrophic factor (GDNF) or the fibroblast growth factors 
(FGFs; Dalton and Mey, 2009). They can be incorporated with microspheres that gradually 
release growth factors (Kokai et al. 2010). Alternatively, the delivery can be achieved by 
introducing cells with the implant. This approach was recently chosen by Allodi et al. (2014), who 
used a collagen matrix seeded with transfected Schwann cells overexpressing FGF-2 inside a 
silicone tube to repair a 6 mm sciatic nerve gap in rats. Other cell types that support PN 
regeneration are several types of stem cells (di Summa et al., 2010; Hu et al., 2013) and olfactory 
ensheathing cells (Dombrowski et al., 2006; You et al., 2011). In addition, structural cues in the 
extracellular matrix, most importantly the Schwann cell-derived basal lamina, play an important 
role in axonal guidance (Johnson et al., 2011; Brooks et al., 2012). To provide a physical substrate 
a number of researchers used biological materials, e.g. silk fibroin and collagen, or synthetic 
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polyesters, e.g. poly(ε-caprolactone) (PCL) and poly-glycolic acid (PGA). Bozkurt et al. (2007) 
developed a collagen matrix with longitudinal pores to facilitate nerve regeneration, and used it to 
reconstruct a biopsy induced sural nerve gap (Bozkurt et al., 2014). Particular attention has been 
paid to the application of longitudinal filaments either as a part of the conduit’s wall or in its 
lumen (Kim et al., 2008; Madduri et al., 2010b; Jha et al., 2011). In a clinical case study, Fan et 
al. (2008) used a chitosan tube with internal filaments of PGA for repair of a 35 mm median nerve 
defect in a patient. Despite these promising studies, the available artificial conduits are not 
considered satisfactory, especially in comparison with autologous nerve grafts. Implants that 
contain live cells are more successful, however, here the issues of immune suppression or of 
finding an appropriate source for the cellular implants arise (e.g. Mey et al., 2012). For this 
reason, I am aiming at a cell-free, artificial implant design that mimics structural features of the 
natural ECM. In preceding experiments, I showed that arrays of electrospun PCL fibers aligned in 
parallel determined the direction of Schwann cell migration and axonal growth. This effect could 
be enhanced when fibers included biological signals, for example by blending PCL with collagen 
(Schnell et al., 2007) or by covalent binding of integrin-activating peptides (Bockelmann et al., 
2011). This was shown first on two-dimensional substrates in vitro and recently transferred to 
three-dimensional (3D) substrates with fibers embedded in collagen hydrogels (see chapter II or 
Kriebel et al., 2014). The design developed in this study showed the potential of such fibers to 
partly mimic basal lamina functions. Based on these results I designed an artificial conduit for PN 
regeneration with an internal structure of sub-micron scale PCL or c/PCL fibers embedded in a 
gelatin matrix. 
In the present study, the suitability of these implants was tested by repairing a 15 mm sciatic 
nerve gap in rats immediately after transection. Functional recovery was assessed via weekly 
behavioral experiments followed by electromyography and histological evaluation of nerves, 
implants and peripheral muscles 12W after surgery. 
2 Material and Methods 
2.1 Manufacture of artificial implants 
To manufacture structured implants of sub-micron scale PCL-fibers in a 3D gelatin matrix 
(implant design referred to as “G1”), 12 wt% PCL in chloroform/methanol (3:1) were electrospun 
onto a stepped target. In this way, a 3D configuration of fibers (Figure 16a and b). For more 
detailed information on the setup, spinning process and fibers see chapter II or Kriebel et al., 
2014. Subsequently, sterile 5% gelatin, dissolved in PBS, was applied onto an object slide to form 
a 1.5 mm thick film into which the fiber array was submerged (Figure 16c). Using hot forceps the 
fibers were detached from the target, and the gelatin was kept on ice for 15 minutes. Two 
razorblades with a fixed distance of 1.5 mm were used to punch out stripes of the gelled films 
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with longitudinal fibers. The stripes were frozen and inserted into hollow collagen conduits to 
form the artificial implant. Empty spaces between conduit wall and internal scaffold were 
cautiously filled up with gelatin solution followed by immediate cooling. For the second design 
(G2) blended c/PCL fibers were  spun from a solution of 12 wt% collagen/PCL (1:3), dissolved in 
1,1,1,3,3,3-hexafluoro-2-propanol. The rest of the procedure was carried out as for G1. The empty 
collagen conduits were provided by a commercial manufacturer and, for comparison, were used 
also in a third group of non-structured implants (ET). 
2.2 Animals and surgical procedure  
For the experiments 10-week old, female Lewis rats of ca. 200 g body were used weight. Animal 
housing and treatment was carried out in accordance with SfN guidelines for animal 
experimentation and with permission of the Landesamt für Natur, Umwelt und Verbraucherschutz 
Nordrhein-Westfalen. There were five experimental groups with 15 rats per group. Of these, three 
were sacrificed after 2W for histological assessment of the biocompatibility of the implants, seven 
after 12W (electrophysiology, behavioral assays, histology) and five after 14 weeks (behavioral 
assays, neuroanatomical tracing, tracing data not included in this study). For surgery, anesthesia 
was induced and maintained via inhalation of an isoflurane/air mixture of 5 % and 3 %, 
respectively, using the Univentor 400 (Univentor High Precision Instruments). The depth of the 
anesthesia was checked by testing of pedal withdrawal and corneal reflexes. The surgical area was 
shaved and disinfected. Animals were placed in a prone position onto a thermostatically regulated 
heating pad to maintain a constant body temperature. Subsequently, the right sciatic nerve, from 
the sciatic notch to the point of trifurcation into peroneal, sural and tibial nerve, was exposed via 
Figure 16 Brief documentation of the fiber production and embedding in gelatin. 
(a) Stair case-like target electrodes for electrospinning were attached to a U-shaped frame 
to allow handling of the fiber array. (b) Electrospun fibers accumulated at the target 
electrodes during the spinning process. (c)  Gelatin (ca. 40°C) was applied onto a glass cover 
slip and fibers were submerged into the gelatin and detached from the target electrodes. 
Subsequently, the gelatin fiber composite was chilled to 4°C. From this, composite stripes 
were produced and inserted into collagen tubes to form implants G1 and G2. 
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incision of the skin and blunt dissection of the thigh musculature. This was followed by the 
excision of a 15 mm piece of the sciatic nerve. According to experimental group, animals 
immediately received one of the following treatments. For an autologous nerve transplantation 
(AT) the excised piece of nerve was re-implanted with epineural sutures using 10-0 monofilament 
nylon (Ethilon, Ethicon Inc., Somerville, USA). For groups G1, G2 and ET the respective 
artificial implants were trimmed to a length of 17 mm and equilibrated for three minutes in cold 
saline. Then the nerve stumps were inserted 1 mm into the ends of the implant and secured with a 
single 10-0 mattress suture. Any residual air bubbles inside the conduits were removed before 
insertion of the proximal stump. In the negative control group (lesion only, LO), the proximal 
stump was embedded in the neighboring thigh muscle and secured with a 10-0 stitch to prevent 
regeneration of axons into the distal stump. Finally, the thigh muscles and the skin were closed 
with 7-0 and a 4-0 suture respectively. For pain relief animals received a subcutaneous injection 
of 0.05 mg/kg body weight buprenorphine hydrochloride (Temgesic). 
2.3 Tissue preparation and immunohistochemistry  
At 2W after surgery and subsequent to electromyography at 12W after surgery, anesthetized rats 
were transcardially perfused using 4 % buffered paraformaldehyde (PFA). Immediately after 
perfusion, the sciatic nerve and muscles of the lower hind limb from both sides were dissected 
post-fixed 24 h with 4 % buffered PFA and stored in PBS containing 0.05 % sodium azide.  
Muscular atrophy: Since the susceptibility to atrophy depends on the predominant muscle fiber 
type (Yamakuchi et al., 2000; Desaphy et al., 2001) four different muscles were weighed, which 
vary in fiber type composition or size. The small Musculus soleus and M. extensor digitorum 
longus have comparable size, but vary in fiber type composition with approximately 95 % slow 
twitch/5 % fast twitch in the first and mostly fast twitch fibers in the second muscle (Soukup et 
al., 2002). The M. gastrocnemius and its antagonist the M. tibialis anterior were more 
heterogeneous and much larger. For muscle weight analysis, muscles were briefly dabbed dry 
with tissue paper and weighed. Muscle weight on the operated side was normalized to the 
contralateral muscle of the individual animal and subsequently averaged per group. 
Nerve regeneration: For sectioning, nerve samples were cryoprotected with 30 % buffered 
sucrose, embedded in Tissue-Tek and snap frozen in isopentane (-80 °C). Using a cryostat, cross 
sections (16 µm) were made from the nerve proximal and distal to the implant (including tibial, 
sural and peroneal branches) as well as from the medial part of the implant, and longitudinal 
sections (16 µm) from the proximal and distal coaptation sites. For immunohistochemistry, the 
sections were blocked for 1 h with 0.1 M PBS containing 5 % normal goat serum (NGS) and 0.5 
% Triton X100, incubated overnight at room temperature in a mixture of primary antibodies, 
diluted in 1 % NGS and 0.5 % TritonX100. A mouse monoclonal antibody was used against β-
tubulin III (T8660, Sigma, 1:1000), rabbit polyclonal antisera against S100 (S2644, Sigma, 
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1:1000) and choline acetyltransferase (ChAT; AB143, Millipore, 1:200). Subsequently, sections 
were washed and incubated for 2 h with Alexa Fluor-conjugated secondary antibodies goat anti 
rabbit IgG (Alexa Fluor 488, A11008, Invitrogen, 1:1000) and goat anti mouse IgG (Alexa Fluor 
546, A11003, Invitrogen, 1:1000) and 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich; 1 
µg/ml) in 1 % NGS and 0.5 % TritonX100. Histological sections were visualized with a Leica 
TCS SP2 confocal microscope (Wetzlar, Germany). 
2.4 Image analysis 
Cross sectional areas of the regenerated tissue in the medial segment of the implant/autologous 
nerve graft were determined using ImageJ 1.46r (NIH, USA). Briefly, the regenerated tissue was 
encircled using the polygon selection tool followed by an area measurement of the region of 
interest. One image per animal and all animals (N ≥ 5) per group were analyzed. 
Axon numbers were counted and the cross sectional area of individual axons determined with 
custom-made MATLAB software (TheMathWorks, Natick, MA). Images of cross sections of the 
medial segment, stained against βIII-tubulin, were converted into binary images using individual 
thresholds set by an observer blind to the treatment conditions of the samples. Thresholds were 
chosen so that during conversion the original data of axon size were conserved as far as possible 
while avoiding confluence of images of individual axons. From the converted binary images, the 
software automatically determined number and size of individual axons. The obtained data were 
checked with manual counting (in 2-3 samples per experimental group). To exclude profiles of 
non-plausible sizes, the software was set to detect only objects within a range of 0.2 -78 µm
2
 
(≈0.5 - ≈10 µm diameter).  
For analyzing the percentage of motoraxons in the total axonal population, images of medial cross 
sections from three individual animals per group, co-stained against βIII-tubulin and ChAT, were 
used. The percentage of ChAT-positive axon profiles that were also positive for βIII-tubulin was 
determined in randomly chosen regions of interest. 
2.5 Electromyography 
The experiments were conducted 12W after initial surgery. Anesthesia was performed as 
described above, and body temperature was controlled using a heating pad. After exposing the 
sciatic nerves on both sides, a bipolar hook electrode was used to stimulate the sciatic nerve were  
proximal to the lesion, close to the sciatic notch. Compound muscle action potentials (CMAPs) 
were recorded from the plantar Musculus flexor digitorum brevis and the M. interosseus pedis 
dorsalis between toes two and three using a monopolar needle electrode. The reference electrode 
was positioned at the contralateral site between the separated thigh musculature. Stimuli were 
rectangular current pulses of 100 µs duration and 30 % supramaximal intensity, determined by 
stepwise increase of the injected current until CMAP amplitude reached a plateau. Absolute 
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intensity was on average 1.76 ± 1.78 mA (mean ± SD). For a single measurement, ten repetitions 
with a frequency of 1 Hz were averaged.  
Signal detection and analysis was performed using custom made MATLAB software. For 
detection of the evoked potential, a threshold slope and, in case of small signals, an amplitude 
threshold was used. The software automatically analyzed the time to first peak, in the following 
referred to as “latency”, and the potential difference between highest and lowest peak, referred to 
as “amplitude”. To correct for differences in amplitude caused by a different impedance of the 
recording electrodes, CMAPs on the operated side were normalized to the corresponding 
contralateral side of the same animal, which was recorded immediately afterwards. For the final 
evaluation, means and SD (N ≥ 5 animals) were calculated for every experimental group. 
2.6 Behavioral experiments 
To assess the recovery of motor functions, toe spread and grip strength baseline values were 
determined on three consecutive days prior to surgery, followed by weekly testing starting 1W 
after surgery.  
For toe spread measurements, animals were placed on a transparent surface with a camera system 
underneath. The animals were lifted up by the experimenter and a sequence of images with 1 Hz 
frequency was produced to gather at least six images, in which the animal was not moving and 
had both feet in one plane. Custom made MATLAB software was used to present the images in a 
randomized fashion to a single blinded observer, who had to mark the position of the 1st and 5th 
toe of both feet. Subsequently, the software determined the mean ratio of the distances between 
the toes of the operated and non-operated hind limb. 
Grip strength was determined using the “Bioseb grip strength test” device. For this, while the 
animal was held by the experimenter, its hind paw was placed on a metal grid fixed to the test 
device. Then the animal was pulled away from the grid, while the maximum force which the 
animal could exert on the bars was measured. Three trials were averaged per animal and time 
point. For the final analysis of toe spread and grip strength measurements, means and SD of all 
animals (N ≥ 11) in the respective groups at a given time point were calculated. 
2.7 Statistical analysis 
Individual animals were considered as independent samples, and means, SD and SEM were 
determined for the experimental groups and time points. Data processing, except for 
electromyography, and statistical analysis were performed using IBM SPSS Statistics Version 21 
(IBM Corp., Armonk, NY, USA). Intergroup differences were tested with ANOVA. After 
Levene’s test, post-hoc comparisons were performed according to Dunnet T3 for unequal 
variances (i.e. analysis of grip strength, toe spread, muscle weight and median axon size) and 
Scheffé for equal variances (i.e. analysis of nerve cross section area and axon count).  Statistical 
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analysis of electromyography data was performed with the MATLAB software.  Intergroup 
differences were tested with ANOVA using post-hoc Bonferroni-corrected t-tests. 
3 Results 
3.1 Artificial nerve implants and general observations 
Based on a recently published technique (Kriebel et al., 2014) artificial nerve guides were 
produced that consisted of a biodegradable tube with a three-dimensional array of longitudinally 
oriented PCL and c/PCL fibers embedded in a gelatin matrix (Figure 16). 
Following surgery the rats recovered well and did not display signs of pain, self-mutilation or 
secondary complications, such as inflammation, throughout the study. Three animals of each 
experimental group were sacrificed at 
2W after implantation. In all cases 
the nerve guides or autologous 
transplants appeared well integrated 
within the host tissue and showed no 
macroscopic signs of neuroma 
formation, or excessive encapsulation 
of the conduit by fibrotic scar tissue. 
At this point in time (2W), the 
collagen tubes were still intact, but light-microscopical investigation revealed no vestiges of the 
electrospun fibers. At 12W after surgery the tubes had been completely resorbed in all animals, 
whereas the non-degradable suture material was still visible (Figure 17). 
 
Figure 17 Tissue regeneration 
following sciatic nerve 
transection (15 mm gap size) and 
subsequent repair using different 
nerve bridges. 
The photographs show (a) a non-
lesioned sciatic nerve (contralateral 
control, CL),b) regenerated tissue 
2 weeks after the insertion of an 
artificial implant (as an example for 
all artificial conduits, which looked 
similar) and (c) regenerated tissue 
12 weeks after the insertion of an 
autologous nerve graft (AT) and 
different artificial implants (ET, G1 
and G2; see text). 
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3.2 Tissue regeneration: macroscopic evaluation of the implants 
Gross examination of the artificial nerve conduits (groups G1, G2 or ET) showed that the conduit 
was surrounded by a thin layer of connective tissue. At the proximal suture sites, the nerve stumps 
were slightly swollen, visibly sealing the ends of the tubes. Inside the conduit a tissue cable with 
clearly visible blood vessels had formed spanning the entire length of the lesion (Figure 17b). At 
the later time point (12W), when the collagen tube had been degraded, the swelling at the suture 
site was reduced at the proximal and had completely disappeared at the distal interface. At both 
proximal and distal coaptation points, a network of blood vessels emerged. The regenerated tissue 
between the proximal and distal nerve stumps had increased in diameter compared to the earlier 
time point in all experimental groups (except the non-implanted group, which lacked a 
regenerated tissue connection between the stumps; not shown). After 12W there was no apparent 
difference between implants G1, G2 and ET, which were still thinner than the autologous nerve 
grafts. Macroscopically, the autografts resembled the non-operated sciatic nerves (Figure 17c). 
3.3 Schwann cell infiltration and axonal regeneration in the implants 
To assess the regeneration inside the implants, longitudinal sections of the coaptation sites 
between nerve stumps and the implants, and cross sections of the proximal, the distal nerve 
stumps and of the mid-section of the implanted conduits were produced.  
An analysis of the cross sectional area of the different implants after 12W confirmed the 
macroscopic assessment of substantial growth in all artificial nerve bridges (Figure 18). The 
regenerated tissue was similar in size in all experimental scaffolds (ET, G1, and G2) and still 
significantly smaller than the resected and 
re-implanted nerves (AT), which had the 
same diameters as the non-operated control 
nerves.  
The inspection of the proximal connections 
between nerves and implants 2W after 
surgery indicated a better ingrowth of 
axons (III-tubulin labeling) and Schwann 
cells (S100 staining) into the internally 
structured implants (G1, G2) than into the 
empty tubes (ET; Figure 19). All groups 
had intense staining of axons and S100
+
 
cells proximal to the lesion. Substantial 
infiltration of Schwann cells and axonal 
elongation was visible in G1, G2 and AT 
grafts at the proximal interface, and some 
Figure 18 Cross sectional area of the 
regenerated tissue in the medial segment 
12W after nerve transection and repair. 
The cross sectional areas of the autologous nerve 
grafts (AT) were unchanged 12W after nerve 
repair, resembling the  non-operated situation 
(CL), tissue that regenerated through one of the 
artificial implants had significantly smaller cross 
sections. There were no differences between ET, 
G1 and G2. Symbols indicate significant 
differences against groups CL (*) and AT (#) 
(p** < 0.01; p*** < 0.001; N ≥ 6). 
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axonal and S100
+ 
profiles could be found in cross sections of the medial segment. In the ET 
group, in contrast, the staining intensity declined abruptly at the proximal interface. At 2W there 
were few axons and S100
+
 cells penetrating the ET conduit, but none were detected in the 
midsection of the implanted segments. Distal to the graft no axons were found in any of the 
groups at this early time point (2W; Figure 19).  
The same assessment was performed 12W after surgery (Figure 20).  In the physiological 
situation, represented by the contralateral, non-lesioned sciatic nerve (CL), axons were evenly 
distributed in the nerve and grouped into a few fascicles. The autograft after 12W showed a 
higher degree of fasciculation but generally resembled the non-lesioned nerve. In the artificial 
Figure 19 Schwann cell infiltration and axonal regeneration at the proximal interface 
between nerve and implant 2W post surgery. 
Longitudinal sections from groups CL (top), ET (middle) and G2 (bottom) stained against 
βIII-tubulin (a, c, e) and S100 (b, d, f) to visualize axons and Schwann cells, respectively. 
Yellow arrowheads point to the collagen tube, which is still present 2W post surgery. The 
weaker staining intensity beyond the interface of nerve and implant in group ET compared 
to G2 indicates a slower infiltration of Schwann cells and axons into the implant. 
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implants multiple small fascicles were loosely distributed over the entire cross sectional area, each 
of them enveloped by a thin layer of connective tissue (Figure 20g-l). In the center of eight of the 
internally structured artificial implants a longitudinal compartment was found, which was devoid 
of axons and Schwann cells but filled with S100
III-tubulin cells (data not shown). Although 
this structure could occupy an area of up to 25% of the regenerated nerves, there was no 
correlation with the quality of functional regeneration.  
Quantification of the number of III-tubulin+ profiles in cross sections of the medial segment 
Figure 20 Schwann cell infiltration and axonal regeneration in the medial segment of 
the regenerated nerve 12W post surgery. 
Cross sections of the medial segment from groups CL, AT, ET and G2 (from top to bottom) 
were stained against βIII-tubulin (a, d, g, j) and S100 (b, e, h, k). Compared to CL and AT, 
nerves that regenerated in the artificial implants show a smaller cross sectional area and 
increased fasciculation. Images of the co-staining with both antibodies at higher 
magnification are shown in (c), (f), (i) and (l), with the biggest axons in AT (apart from CL) 
and the smallest in ET. Schwann cells enwrapping single axons can be seen in AT and G2 but 
less so in ET. 
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revealed no differences between the non-injured nerves and the autologous implants, whereas the 
artificial implants contained significantly fewer axons (Figure 21a). In all three groups (ET, G1, 
G2) about 3.400 axonal profiles per cross section were counted, about half of the number 
contained in the control nerves. Interestingly, the number of III-tubulin+ profiles in the medial 
segments of the AT group was higher than in control nerves (CL) and also higher than proximal 
to the lesion, even though this difference was not statistically significant. In all nerve repair 
groups with artificial implants an increase in the number of axonal profiles was observed from the 
midsection of the implant to the distal segment (significant for G1 and G2; p < 0.05 and p < 
0.001, respectively), suggesting that sprouting of regenerating axons at the distal coaptation point 
had taken place.  
Apart from the number of all regenerating axons, the efficacy of the different implants to support 
regeneration by motor neurons was investigated. Using immunostaining against ChAT (Figure 
22a-b) the percentage of motor axons among the total population of axons (III-tubulin+, i.e. 
motor, sensory and autonomic axons) in the midsection of control and regenerated nerves were 
Figure 21 Quantitative analysis of the regenerated nerve tissue. 
Panel (a) shows the number of individual βIII-tubulin+ profiles (regenerated axons) in cross 
sections of the medial segment (significant difference against CL and AT are indicated as * 
and #, respectively; p<0,001; N≥6), (b) size distributions of βIII-tubulin+ profiles, step size 
1µm2, and (c) their cross sectional areas in µm2 in the different groups. The solid and dashed 
lines in c indicate median and mean, respectively; the boxes 25 - 75 %, whiskers 10 – 90 % 
and dots 1 % and 99 %. 
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determinded. Depending on the experimental group this percentage ranged from 32.1 ± 1.2 % 
(G1) to 37,1 ± 5.4% (CL) with no significant difference between any of the groups or the non-
operated control nerve (Figure 22c).  
3.4 Size distribution of regenerated fibers  
High magnification images revealed considerable differences in the thickness of axons and 
association of Schwann cells with the fibers in the different groups. Cross sections of non-
lesioned sciatic nerves showed many large and roughly circular or elliptical axonal profiles that 
were regularly encircled by S100
+
 Schwann cells (Figure 20c). Non-lesioned nerves exhibited 
regions of predominantly bigger or smaller axons with a gradual transition between them. This 
was different in the tissue 12W after nerve repair (Figure 20f, i, l) Axons were generally smaller 
and the fewer large diameter axons were randomly intermingled with the mass of small axons. 
The diameters of III-tubulin+ profiles were for CL: 6.0 ± 3.2 µm (mean +/- SD), AT: 3.4 ± 2.0 
µm, G1: 3.9 ± 1.8 µm, G2: 5.1 ± 2.1 µm, and ET: 3.1 ± 1.5 µm. The size distribution of III-
Figure 22 Similar percentage of regenerating motoraxons in all implants. 
Immunostaining against βIII-tubulin (red) and ChAT (green) was used to identify 
motoraxons in cross sections from repaired (mid of lesion) and non-operated sciatic nerve 
samples (exemplary image from CL). Only motoraxons are characterized by co-localization 
of both antibodies (examples: white arrowheads). Quantification of the ratio of motoraxons 
to the total axonal population revealed no difference between the different experimental 
conditions and the non-operated contralateral nerve. 
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tubulin
+
 profiles (Figure 21b) confirmed that small axon diameters were relatively more abundant 
in the regenerated nerves. When comparing these groups, I found the number of large caliber 
axons (larger than 10 µm
2
 cross section) to decrease from AT (548 ± 94; mean ± SEM) to G2 
(389 ± 44) and G1 (307 ± 74) to ET (209 ± 29). For the non-lesioned nerve the value was 1378 ± 
130. The median axon diameter was largest in the non-injured nerves, and this was significantly 
different only from the ET group (p < 0.05), which had the smallest fibers (Figure 21c). The only 
other experimental group with a significantly larger median of axon diameters compared to ET 
was the G2 construct. It was not the case for AT because of a large number of regenerated small 
fibers. 
As with the axons, the appearance of S100
+
 positive profiles was less regular in the repaired 
situation compared to control nerves. However, most S100
+
 positive profiles in samples from 
group AT displayed a clear circular shape suggesting a myelinating phenotype, and this was 
confirmed with staining against myelin basic protein (data not shown). This pattern was also 
observed in groups G1 and G2, however there were also Schwann cells that did not show a clear 
interaction with one axon, thus likely to have a non-myelinating phenotype. This observation was 
even more pronounced in group ET (Figure 20i). In summary, judging the maturity of regenerated 
axons by diameter and state of myelination, I saw the highest similarity with the non-lesioned 
nerve in the AT group, a lesser degree in the structured implants G1, G2, and very little of this 
organization in the ET control group.  
3.5 Functional regeneration: electromyography 
At the endpoint of this study, 12W after sciatic nerve transection and repair, functional 
regeneration was assessed by recording of CMAPs from the plantar Musculus flexor digitorum 
brevis (Mfdb) and M. interosseus pedis dorsalis (Mipd), both innervated by the tibial branch of 
the sciatic nerve. CMAPs were induced with electrical stimulation of the sciatic nerve proximal to 
the lesion site (Figure 23a, traces of typical recordings). The successful recording of induced 
electrical muscle activity in all rats that received autologous transplants (AT) or scaffolds with 
PCL-fibers (G1) and in five of the six animals that received c/PCL-fiber constructs (G2) 
demonstrated that the new artificial implants supported nerve regeneration including re-
innervation of target tissue. In contrast, I was only able to record CMAPs in half of the animals in 
the group that received an empty collagen tube (ET). As anticipated, no CMAPs could be 
recorded from the negative control group (lesion only, LO; Figure 23b).  
To evaluate the functional quality of regeneration in more detail, I analyzed amplitude and latency 
of the recorded potentials (Figure 23c, d). The CMAP amplitude is dependent on the number of 
functional motor units and the temporal coherence of nerve excitation in the vicinity of the 
electrode, hence gives an indication of the number and quality of regenerated motor axons.  For 
group AT I found the strongest recovery with 48 % of the CMAP amplitude recorded, compared 
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to the non-lesioned contralateral side (Mipd). The second highest CMAP amplitudes were found 
in G2 (22 %) followed by G1 (16 %) and the lowest in ET (10 %, Table 1). The differences 
between the artificial constructs were not significant. 
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Figure 23 Electromyography performed 12W after sciatic nerve repair. 
(a) Exemplary recordings of the compound muscle action potential (CMAP) from Musculus 
flexor digitorum brevis (Mfdb) for different experimental groups after sequentially 
increasing stimulus intensities (grey lines) up to a 30% supra-maximal stimulus (black 
line). The arrow indicates the time of stimulation. (b) Percentage of animals that showed 
CMAPs indicating successful reinnervation. The number in white bars indicates the sample 
size while the colored bars indicate the number of animals with evoked CMAPs from at least 
one muscle (Mfdb or Mipd). (c) CMAP amplitude of Musculus interosseous pedis dorsalis 
(Mipd) on the lesioned side was normalized to the contralateral (non-lesioned) side (grey 
dots). (d) CMAP latency (time to first peak) of Mipd on the lesioned side and the 
corresponding contralateral side (grey dots). Black bars in c, d indicate mean ± SD; asterisks 
mark significant differences with respect to group AT (p** < 0.01; p*** < 0.001; N ≥ 5). The 
difference to the contralateral side within individual groups was always significant 
(p < 0.001). (e) Data from both muscles were pooled and CMAP amplitude plotted against 
latency. The graph reveals a clear negative correlation between both parameters, and 
recordings from individual groups are distinctly clustered. 
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Table 1 Compound muscle action potentials after PN repair with artificial implants 
Data are means ± standard deviation. The number of rats of whom CMAPs could be recorded 
were for AT: n = 6, ET: n = 3 G1: n = 7, G2: n = 5 (animals without CMAP recording in groups 
ET and G2 are excluded from latency data). CMAP amplitude of the non-lesioned nerve was 
set to 100 % individually. 
 
The maturity of regenerated axons can be assessed by measuring CMAP latency, which are  
considered to be influenced by axon diameters and the degree of myelination. The same relative 
ranking between the experimental groups that I found with response amplitude was also observed 
when comparing latencies between electrical stimulation and CMAP (Table 1). Shortest latencies 
were determined in group AT. While differences between the three artificial implants were not 
significant, the shorter mean latencies of construct G2 compared with G1 and ET again indicated 
an advantage of the c/PCL-fiber containing matrix. 
Latency and amplitude of the CMAPs were negatively correlated. The CMAPs of non-lesioned 
nerves had relatively high amplitudes (many motor units were activated simultaneously) 
combined with short latencies (high conduction velocities of the stimulated fibers), whereas a 
combination of low amplitudes and long latencies were seen when regeneration was poor.  
When plotting CMAP amplitude vs latency the graph describes a hyperbola that asymptotically 
approaches the abscissa (Figure 23e). Data of the non-injured controls and the two implant groups 
AT and G2, form clusters along this function, illustrating the rank order between these groups that 
are characterized by successful recovery. Data points for groups ET and G1 tend to form a single 
cluster at the bottom end of the function indicating an inferior recovery according to 
electromyography, compared to the other treatments. 
  
  
CMAP amplitude 
[% of control] 
CMAP latency 
[ms] 
 
M. flex. dig. brev. 
M. inteross. ped. 
dors. 
M. flex. dig. brev. 
M. inteross. ped. 
dors. 
non lesioned side 
(CL) 
100 100 3.21 ± 0.22 3.07 ± 0.31 
lesion only (LO) 0 0 n.a. n.a. 
autograft (AT) 41.4 ± 5.5 47.7 ± 10.3 4.67 ± 0.24 4.71 ± 0.26 
empty tube (ET) 5.7 ± 8.9 10.1 ± 11.4 6.23 ± 1.03 6.11 ± 0.28 
PCL-implant (G1) 17.1 ± 7.9 15.6 ± 6.9 6.65 ± 0.51 6.74 ± 0.65 
C/PCL-implant (G2) 21.5 ± 15.8 22.1 ± 16.4 5.81 ± 1.01 5.89 ± 0.98 
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3.6 Functional regeneration: recovery of motor functions 
The crucial outcome with respect to PN regeneration is the recovery of appropriate motor 
functions. To investigate the implications of nerve transection and the progress of regeneration 
after nerve repair using different implants, behavioral experiments were performed weekly 
starting 1W after surgery. At that time point, all animals exhibited paralysis and avoided the use 
of the lower hind limb on the operated side. Behavioral observations of the rats confirmed the 
completeness of the nerve transection and the gradual regeneration. Two quantitative measures, 
toe spread on response to lifting the animal and grip strength, revealed when the animals regained 
motor functions of their hind paws. 
The toe spread score measures the ability to extend and abduct the digits. In the days following 
surgery the affected paw showed a flat or passive posture with extended toes and reduced spread 
between digits 1 and 5 compared to baseline (Figure 24 a, b). In the following weeks, toe spread 
decreased further, reaching a minimum of approximately 30 % of baseline 3W after surgery. For 
the animals with sciatic nerve lesion but no implant, the toe spread value remained at this value 
without improvement until the end of the experiment at 12W. In the animals with nerve implants, 
toe spread began to increase and by 12W had recovered to a large extent (up to 75% compared to 
the contralateral paw). Compared to the non-repair group this recovery was significant for groups 
AT, G1 and G2 but not for the ET group (Figure 18b). 
The grip strength test measures the muscular force exerted by the digits when flexing or grasping 
a metal grid. Consistent with the paralysis in the operated lower hind limb, all animals failed to 
exert any additional force beyond mere friction as the paw moved across the metal bar surface  
during the first weeks after surgery (i.e. below 15 N, dashed line in Figure 24c). Starting at 6W 
after surgery, the first animal (in group AT) exhibited a change from an extended to a flexed 
posture of the affected toes. Mean grip strength of group AT started to recover 7W after surgery 
and, from then onwards, showed a steady and linear increase. The groups with artificial nerve 
grafts also showed regeneration starting to recover in approximately one week intervals, with 
group G2 being first, followed by G1 and ET last. In these cases the observed functional recovery 
was more modest, starting later and developing with a lower slope (Figure 24c). At the endpoint 
(12W after surgery) mean grip strength for all groups with the exception of ET was significantly 
larger than that of the group without implant (LO, Figure 24d). This outcome was reflected in the 
higher number of ET individuals compared to the other groups, that did not exhibit grip strength 
above 15 N, considered as no recovery, during the time of the study. While this threshold was 
reached by 100 % (11/11) of the individuals in groups AT and G1, and by 75 % (9/12) in group 
G2, only 25 % (4/12) in ET exhibited a detectable increase in grip strength. 
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Figure 24 Behavioral analysis of nerve regeneration. 
Following surgery the recovery of the toe spread reflex and grip strength was investigated 
once per week. (a) The toe spread reflex was investigated by measuring the distance 
between toes 1 and 5 on the operated and non-operated legs. (b) The toe spread ratio of the 
operated to the non-operated side is plotted for the different conditions at the 3W (white 
bars) and 12W (colored bars) time point. It drops immediately after the operation, declines 
further to a minimum at 3W for all groups and recovers in groups AT, G1 and G2. (c) Grip 
strength development over time illustrates the degree of functional regeneration. A 
threshold of resistance without muscular activity (dashed line) was never surpassed by any 
rat of group LO. Plot (d) shows the grip strength before surgery (baseline) as well as 1W 
(white bars) and 12W (colored bars) post-surgery, respectively. Error bars indicate SEM, 
asterisks significant differences to the mean of group LO 12W post surgery (p** < 0.01; 
p*** < 0.001; N ≥ 11). 
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3.7 Muscular atrophy and regeneration 
A secondary effect of the denervation after nerve transection is muscular atrophy due to the lack 
of activity. To the extent that this is caused by the degradation of proteins in muscle fibers which 
survive, reinnervation can initiate new growth of muscle mass.  To include different muscle fiber 
types in the analysis the weight of four muscles of the lower hind limb were measured, i.e. M. 
soleus, M. extensor digitorum longus, M. gastrocnemius and its antagonist the M. tibialis anterior. 
(Table 2 and Figure 25). Denervated muscles lost approximately 50 % of their weight in the first 
2W after nerve transection. This was similar in all experimental groups and independent of the 
type of implant the animals had received. With sustained denervation, as in the non-repaired 
situation (LO), muscle weight decreased further, reaching 26 % (average of all four muscles) after 
12W. In animals that received one of the artificial implants this continuing decline in muscle 
weight was prevented. After termination of the experiment their muscles were only slightly 
smaller than 2W after surgery, and this difference was not significant. Given that reuse of re-
innervated muscles began later than 6W even in the AT group (Figure 24c), these results indicate 
a recovery of muscle weight after reaching a minimum sometime between 2W and 12W. Only 
animals treated with an autologous nerve graft (AT) showed considerable recovery of muscle 
weights beyond the values obtained 2W after surgery. The average muscle weight in group AT 
reached 71 % of the non- lesioned side. 
Figure 25 Determination of muscular 
atrophy. 
Following nerve transection the denervated 
muscles start to atrophy. (a) Tibialis anterior 
muscles from the operated leg 12W post 
surgery of experimental groups (LO, AT, G1) 
exhibit different degrees of atrophy. For 
comparison, the corresponding contralateral 
muscle (CL) is shown. (b) Atrophy was 
quantified by determination of the weight of 
four muscles of the lower hind limb (see text) 
at 2W (white bars) and 12W (colored bars) 
post surgery. Muscle weight of the operated 
leg was normalized individually to the 
contralateral side. For the graph the relative 
weight of all four muscles of every animal was 
averaged. Error bars indicate SEM, asterisks 
depict significant difference to LO at the 
respective time point (p*** < 0.001; N2W ≥ 2; 
N12W ≥ 6). 
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4 Discussion 
The quality of autologous nerve grafts to support functional recovery after PN injury remains 
unmatched. Yet, their disadvantages, including the need for additional operations and the limited 
availability of donor material create a demand for alternatives based on the use of acellular, 
allogenic implants or artificial implants. In the present study, I tested the efficacy of an internally 
structured scaffold to promote PN regeneration over a 15 mm sciatic nerve gap in rats. These 
artificial implants contained aligned sub-micron scale PCL-fibers as longitudinal guidance cues 
embedded in a gelatin matrix. It was derived from the design I documented in chapter I (see also 
Kriebel et al., 2014), but  with modifications regarding the gelatin hydrogel for embedding the 
fibers (instead of collagen),  and the choice of the surrounding tube. In its molecular composition 
gelatin is closely related to collagen. I found that the gelling characteristics of gelatin facilitated 
implant assembly and storage of the prepared scaffolds, while offering the possibility to sterilize it 
before use. In addition, gelatin is much cheaper than collagen. For the hollow nerve conduit I used 
a collagen tube instead of the previously used hand-made PCL tubes. Based on the recovery of 
motor functions and on electrophysiological assessment of the regenerated nerves the structured 
implants represent a significant improvement on the conventional hollow conduits and offer 
possibilities for further optimization. A modification of the fibers by blending the PCL with 
collagen before electrospinning produced an additional positive effect on regeneration. 
Table 2 Muscle weight normalized to the corresponding muscle on the contralateral 
side 2 and 12 weeks after respective treatment. 
Data are % of individual contralateral muscle (CL) given as means ± standard deviation. 
 M. 
gastrocnemius 
M. tibialis 
anterior 
M. soleus 
M. extensor 
digitorum longus 
 
2 
weeks 
12 
weeks 
2 
weeks 
12 
weeks 
2 
weeks 
12 
weeks 
2 
weeks 
12 
weeks 
non lesioned 
side (CL) 
1,38g ± 
0,18g 
1,16g ± 
0,09g 
0,51g ± 
0,10g 
0,40g ± 
0,04g 
0,13g ± 
0,01g 
0,12g ± 
0,01g 
0,12g ± 
0,02g 
0,09g ± 
0,01g 
lesion only 
(LO) 
47,76 ± 
5,20 
17,30 ± 
1,92 
47,12 ± 
3,59 
24,24 ± 
1,90 
46,73 ± 
4,08 
34,69 ± 
6,97 
48,78 ± 
6,22 
29,13 ± 
1,51 
autograft (AT) 
43,69 ± 
1,43 
55,95 ± 
5,69 
48,07 ± 
0,06 
72,94 ± 
3,57 
50,82 ± 
1,39 
69,50 ± 
14,56 
46,14 ± 
0,16 
86,06 ± 
6,70 
empty tube 
(ET) 
44,80 ± 
1,06 
31,64 ± 
12,06 
50,46 ± 
4,80 
46,97 ± 
19,79 
51,11 ± 
0,47 
42,40 ± 
19,92 
51,63 ± 
0,89 
51,36 ± 
18,90 
PCL-implant 
(G1) 
47,50 ± 
2,60 
40,65 ± 
8,37 
54,66 ± 
4,37 
49,33 ± 
10,12 
53,95 ± 
7,35 
45,48 ± 
6,69 
58,73 ± 
0,76 
60,62 ± 
8,98 
C/PCL-implant 
(G2) 
48,45 ± 
0,68 
37,74 ± 
9,91 
53,76 ± 
5,49 
50,45 ± 
16,63 
51,30 ± 
3,91 
43,18 ± 
11,60 
67,30 ± 
3,74 
57,81 ± 
18,53 
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4.1 Regeneration in the artificial nerve implants 
Following a PN crush lesion, the distal sections of the transected axons degenerate, and activated 
Schwann cells and macrophages phagocytose cellular debris (Deumens et al., 2010). Structural 
reorganization follows, characterized by a longitudinal alignment of proliferating Schwann cells 
and basement membranes. These form bands of Büngner, which guide regenerating axons from 
the proximal stump to targets in the periphery (Christie and Zochodne, 2013). Similar processes 
promote regeneration in an autologous nerve transplant. Although the ECM and secreted factors 
of an injured PN create a permissive environment for axonal growth, regeneration is initially 
slow, because proximal axon endings degenerate back to the last node of Ranvier before the 
metabolic changes take place that induce the formation of growth cones (Deumens et al., 2010). 
Even in case of a direct end-to-end suture after sciatic nerve transection in mice it was reported 
that only 17% of the axons had crossed the repair site after five days (Witzel et al., 2005). 
When a large nerve gap is bridged by fluid-filled tubular implants, bands of Büngner are not 
available, which complicates regeneration: Within the first week after surgery a reconnection of 
the proximal and distal nerve stumps is initiated by the formation of a cord of longitudinal fibrin 
(Weis et al., 1994; McDonald and Zochodne, 2003). How this first tissue bridge is produced in 
detail remains to be elucidated. Several publications indicate that perineurial glia cells and 
fibroblasts are involved in the process (Scaravilli, 1984; Weis et al., 1994), and my observation of 
central strands filled with S100
-
/IIItubulin-/MBP- cells in regenerated nerves within artificial 
conduits at 12W may reflect it. 
Subsequently, Schwann cells infiltrate the lumen of the conduit. Migrating along the bridge of 
connective tissue, they proliferate and deposit other ECM material including a laminin-containing 
basement membrane. On this substrate regenerating axons from the proximal stump follow up 
closely (Zochodne, 2012). In my experiments, axons were detectable at 2W in the medial segment 
of the internally structured implants, but they were few compared to the endpoint observation at 
12W. This may be expected, given that previous studies (Witzel et al., 2005) demonstrated that 
axonal regeneration does not occur simultaneously but successively, with a few pioneering axons, 
which are followed by consecutive waves of regenerating fibers. Based on the histological 
evidence of an internal connective tissue fascicle after 12W that was surrounded by Schwann cells 
and axons, I surmise that the formation of a connecting fibrin cable occurred also in the gel- and 
fiber-containing implants. Although the physiological and functional data demonstrated better 
regeneration in the structured implants compared to the merely fluid-filled tubes, the histological 
evaluation was not suitable to demonstrate that axons or Schwann cells actually moved in contact 
with these substrates. It is also possible, that the positive effect of  the internal structure was 
primarily based on aiding the formation and stabilization of the fibrin cable, the very first step in 
regeneration, as suggested by Koh et al. (2010). Axon counting revealed that not all axons entered 
into the artificial implants but that axonal branching must have occurred when axons crossed the 
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distal coaptation site and regrew into the denervated distal stump. Branching of fibers was also 
observed within the autologous transplants at the proximal coaptation site, as reported before 
(Jenq and Coggeshall, 1985; Miyamoto et al., 1985; Witzel et al., 2005). This observation 
suggests that branching of axons is induced through contact or trophic factors released from a 
nerve undergoing Wallerian degeneration, which could be either the distal stump or an autologous 
nerve graft.  
Since the time needed for reinnervation of a target tissue depends on the type, -size and location 
of injury, it is difficult to compare the speed of recovery in the present implants with data from 
the literature (Cao et al., 2011; Yu et al., 2011; van Neerven et al., 2012; Kim et al., 2014). 
Nevertheless, my analyses of grip strength recovery and muscular atrophy are in accordance with 
previous studies. After making a 10 mm sciatic nerve lesion in rats at mid-thigh level and 
subsequent repair with an autologous nerve graft, a duration of 6-7 weeks until reinnervation of 
the gastrocnemius muscle has been reported (Korte et al., 2011; Kim et al., 2014). Other 
researchers (McCallister et al., 2001) autografted a 10 mm gap in the rat sciatic nerve and 
observed a remaining muscle weight of the M. tibialis anterior of 62 % at 12w after injury (73% 
in the present study) while the controls without repair had 29 % (24 % in the present study). The 
better results of the present autograft is likely to be due to the fact that McCallister and colleagues 
reversed the orientation of their short nerve graft before re-implantation, whereas larger lesions of 
the present study and also those of Bozkurt et al. (2012) made the reversal of the graft impractical, 
and therefore was not performed. Given the general agreement with published data concerning 
autologous transplants the data about the structured artificial implants presented here may be put 
into perspective. Thus, the novel PCL- and c/PCL-fiber containing gels represent a significant 
improvement on standard implants without internal guidance structure, although they do not reach 
the quality of autologous nerve grafts or allografts (Brooks et al., 2012). 
4.2 The importance of an internal guidance structure in artificial implants 
The only FDA and CE approved alternatives to autologous transplants are simple tubes  
applicable for short distance repair (less than 2-3 cm). As corroborated here, they are inferior to 
autologous transplants, and the integration of molecular and structural cues for reaching a 
comparable functional outcome remains a challenge (Lundborg, 2000; Isaacs, 2010; Konofaos 
and Ver Halen, 2013). Since fluid-filled tubes provide no substrate for axonal growth in their 
lumen, it is only after some time, when a continuous tissue bridge has formed and infiltration of 
perineurial and Schwann cells has occurred, that axons can start to grow into the implant (Lewis 
and Kucenas, 2014). On the other hand, the potential for successful regeneration diminishes with 
the time after injury (Xu et al., 2014), implying that the presence of a growth substrate may be an 
important factor for functional recovery within a critical window of opportunity. I therefore 
attribute the better functional outcome in my experimental groups to the incorporation of 
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electrospun fibers that serve as longitudinal guidance cues (as shown in vitro: Schnell et al., 2007; 
Kriebel et al., 2014) and not to the gelatin substrate surrounding them. This statement does not 
diminish the importance of the choice of the hydrogel and its physical properties. Generally, cells 
need surfaces to grow on and migrate, and in situations when the hydrogel forms a distinct 
boundary with the surrounding medium, as observed with alginate and fibrin gels, cells tend to 
grow along this interface rather than penetrating the gel (Mohanna et al., 2003; Gerardo-Nava et 
al., 2014). This prevents regeneration within the intended structure. To avoid such effects I 
decided to use non-fixed gelatin as a support for the fiber arrays. Kept cold, it allowed handling 
and incorporation of the fibers into the tube, while at body temperature it became liquid again and 
thus did not pose an obstacle for cells involved in regeneration. 
4.3 Implementation of biological signals in synthetic cell-free nerve grafts 
Under the condition of nerve crush with intact perineurial sheaths (axonotmesis) multiple 
molecular signals on the ECM and molecules released from the Schwann cells induce axonal 
regeneration. Hydrogels and electrospun fibers can provide a platform to present selected signals 
in artificial implants (Dalton and Mey, 2009). Soluble growth factors, e.g. nerve growth factor 
(Xu et al., 2003) and glial growth factor (Mohanna et al., 2003) were successfully used in this 
context. Another option consists in functionalization of implanted surfaces with activators of 
integrins and cell adhesion molecules (Klinkhammer et al., 2010; Grafahrend et al., 2011). 
Already the implementation of one type of integrin-activating peptide (RGDS) on electrospun 
fibers increased their ability to induce Schwann cell migration and axonal growth (Bockelmann et 
al., 2011). 
Considering that the implantation of living cells has serious practical disadvantages, such as 
additional  operations for harvesting endogenous cells or immune suppression, my strategy 
focuses on the development of cell-free artificial nerve bridges. Two recently developed acellular 
products that contain internal guidance structures are the Avance® and Neuromaix® nerve 
implants. Both incorporate some biological activity because they are derived from natural 
materials. The Avance (AxoGen Inc., Alachua, FL) nerve graft is marketed as the “only off-the-
shelf commercially available processed nerve allograft intended for the surgical repair of PN 
discontinuities”. Recovered from human PN, which are cleaned from cellular debris, the grafts 
preserve the ECM structure of the PN and have been reported to show similar axon regenerating-
promoting properties as autologous nerve grafts (Brooks et al., 2012). Neuromaix (Matricel 
GmbH; Herzogenrath, Germany) consists of an orientated scaffold with longitudinal pores that is 
produced from porcine collagen type I using a patented freezing protocol. Animal experiments 
with this scaffold were also successful (Bozkurt et al., 2012), and a clinical phase 1 trial is 
currently under way (Bozkurt et al., 2014). 
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Several disadvantages with these products make the further development of synthetic nerve grafts 
with specific biological signals desirable: The AxoGen scaffolds still require harvesting of human 
tissue and result in limited control over the material properties. The Matricel scaffold has mostly 
the signaling properties of collagen type I via α2β1 and integrins (Bozkurt et al., 2007; Knight et 
al., 1999). While the constructs presented here are not likely to be superior to these products, my 
approach opens the possibility to use completely synthetic hydrogels and fibers and to endow 
them with signaling peptides designed to activate integrin receptors. Further improvements of the 
present scaffold may be achieved by additional functionalization of the electrospun fibers 
(Bockelmann et al., 2011; Grafahrend et al., 2011) and/or the application of growth factors that 
are gradually released (Lee, 2003; Solorio and Zwolinski, 2010) 
5 Conclusion 
Based on the recovery of motor functions and on physiological assessment of the regenerated 
nerves the novel structured implants represent an improvement on conventional hollow conduits 
and offer possibilities for further optimization. By elaboration of structural properties (e.g. fiber 
density) or by providing more information on the interaction of the involved cell types with 
biological signals it should be possible to further narrow the functional gap between artificial 
implants and autologous nerve grafts. 
 
Comparison to other studies 
83 
 
General Discussion 
Peripheral nerve lesions not only may have drastic consequences for the affected individual but, at 
the level of the population, also considerable socio-economic impact. This is particularly due to 
the high follow up costs generated by these injuries. Reasons for that are, for example, the long 
term physical therapy the patient has to undergo to support functional recovery. Furthermore, 
until this is achieved to a satisfactory degree, if at all, the patient will not be at his full 
professional capacity. To facilitate best possible recovery for the patient and reduce the total costs 
for the society, it is necessary to have treatments available with a prospect for recovery at least on 
the level of the autologous nerve graft. However, as stated before, a direct end-to-end 
neurorrhaphy is not always possible, nor is an autologous nerve graft always available. Hence, at 
the moment there are cases were the physician in charge has to make use of alternatives that 
might be less promising than the aforementioned solutions, e.g. an artificial implant. Therefore, 
there is great interest in improving the performance of artificial implants especially for the 
treatment of bigger nerve gaps. 
To achieve this, different strategies can be applied, as elaborated in Chapter I of this thesis. The 
approach presented here aimed for the integration of sub-micron scale fibers as a guidance 
structure into a hollow conduit to obtain a cell-free artificial nerve implant with improved 
performance, compared to the hitherto available conventional implants. For this, I designed and 
established an electrospinning device for the production of 3D arrays of aligned fibers. These 
arrays were embedded in a hydrogel matrix to form a scaffold with an internal guidance structure. 
After showing via in vitro experiments that the fibers keep their guidance properties inside the 
hydrogel, fiber/gel constructs were incorporated into collagen tubes to obtain implantable devices. 
Subsequently these were used to bridge a 15 mm rat sciatic nerve gap in vivo. It showed that, even 
though the autologous nerve graft still performed notably better, the incorporation of the fiber/gel 
constructs proved to be beneficial for the outcome of regeneration compared to hollow collagen 
tubes. Thus I consider this approach a promising basis for further improvements. However, there 
have also been other approaches in the past years, of which a representative selection will be 
presented briefly in the following. 
Comparison to other studies 
The suitability of electrospun fibers as guidance structures for peripheral nerve regeneration has 
also been demonstrated in other studies. In two consecutive in vivo studies with rats by Ravi V. 
Bellamkonda‘s group (Kim et al., 2008; Clements et al., 2009), films of longitudinally aligned 
fibers from PAN-MA were incorporated into polysulfone nerve conduits to successfully bridge a 
tibial nerve gap of 17 and 14 mm, respectively. In the first study they also performed nerve repair 
with an empty (saline-filled) polysulfone conduit and an autologous nerve graft, which, to a 
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certain extent, allows a comparison between their approach and mine. In  their study, as in mine, 
the best regeneration was found in the group of animals that was treated with an autologous nerve 
graft. This was relatively closely followed by the aligned fiber-film group, and the differences 
between autograft group and aligned fiber-film group seem smaller than in the present study. This 
observation can be explained by several reasons. First of all, the more distal location of the nerve 
defect (tibial versus sciatic nerve) generally has a better prediction for functional recovery. In 
addition, the outcome of regeneration was assessed only 16 weeks after implantation, which is 
four weeks later than in the present study. Surprisingly, in contrast to my study, they did not find 
any signs of regeneration in the empty conduits even though the nerve gap to be bridged was only 
2 mm longer in their study (17 versus 15 mm). This creates the impression that differences 
between autograft group and aligned fiber-film group are smaller than observed in the present 
study, allthough this might not be true. However, the data in general suggest a slightly better 
performance of their approach compared to mine. 
Another example for the successful application of electrospun fibers to perform a PN repair in rats 
is the work by Jha et al. (2011). The unique feature of this work is the very convenient procedure 
to obtain the internally structured implants. By electrospinning onto two rounded target electrodes 
a bundle of aligned fibers was created. In a second step an exterior coating was added to the 
construct by electrospraying PGA:PLA copolymer onto the outside of the bundle and thus 
forming the final construct. Unfortunately they only used a nerve gap size of 10 mm for biological 
testing and stopped the experiment seven weeks after implantation. At this time point the animals 
showed a withdrawal reflex in response to foot pinch, indicating sensory reinnervation. This 
coincides with the regain of grip strength in the present study, but a more detailed comparison is 
hindered by the differences in experimental conditions. 
Besides the application of fibers, specifically processed hydrogels have also been used to 
implement directional cues into nerve conduits. One way to achieve this was demonstrated by 
Yao et al. (2010). They produced collagen nerve conduits with multiple internal channels with 
diameters of approximately 500 µm to limit axonal dispersion inside the conduit and thus reduce 
inappropriate target reinnervation. While this aspect of the study seemed to be a success, as they 
found that even fewer neurons showed double projections to the tibial and the peroneal branch in 
the 4-channel group as in the autograft group, the actual regenerative outcome did not differ 
between their implants and a conventional hollow collagen conduit when used to repair a 10 mm 
sciatic nerve gap in rats.  
An alternative approach was used by Bozkurt et al. (2012) who employed a conduit material 
called Perimaix. This material, developed by Matricel GmbH (Herzogenrath, Germany), is 
derived from porcine collagen that was further processed through cross-linking and directional 
freezing to create longitudinal pores for cellular and axonal guidance (Bozkurt et al., 2009). 
Bozkurt and coworker used the Perimaix conduit to bridge a 2 cm sciatic nerve gap in rats. This is 
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expected to be a challenging gap size for the application of artificial implants and probably the 
largest possible distance to repair in this animal model. Nevertheless they were able to show that 
six weeks after implantation axons had crossed the complete implant and depicted the same 
diameters as in the autograft group. However, axon density and myelin thickness was reduced to 
approximately 50 and 66 %, respectively, of that determined for the autograft group 
demonstrating that the nerve transplant was still superior to the artificial scaffold. Functional 
recovery was not assessed in this study. A notable difference to most other studies, which might 
have had a positive effect on regeneration is the absence of a conventional tubing material. 
Instead they opened the nerves epineurium by a longitudinal incision at the site of nerve defect 
and later on used it to ensheath the inserted implant, embedding it in a much more natural 
environment. Again, the differences in the experimental conditions in addition to the lack of a 
comparable negative control (empty tube) do not permit a detailed comparison between this and 
the study presented here. However the quality of axonal regeneration across such a defect size is 
impressive and led to consecutive clinical testing of the material in humans (Bozkurt et al., 2014). 
To conclude, one first of all one has to recognize that comparison between different studies is 
difficult in general. Even though the selection presented here is restricted to only one of several 
animal species (e.g. rabbit, dog, sheep) used for PN repair studies, there is still a considerable 
variability of experimental conditions impeding detailed comparison. These are, for example, the 
choice of nerve, defect size, time of recovery and methods for its assessment. Thus, even though 
there is a lot of research going on in the field, it is difficult to rank the success of my own 
approach in relation to alternative ones. A demand for standardization of peripheral nerve repair 
studies with rodents has already been voiced by others (Bozkurt et al., 2012). This would greatly 
help to identify the most promising strategies, discard others and accelerate progress in this field 
of research.. Apart from that, the selection of studies presented here suggests that my implant 
design is not generally superior but competitive to other approaches with internal guidance 
structures. However, it seems that the incorporation of physical/topographical guidance cues only 
is not sufficient to achieve results on the level of autologous nerve grafts. Further augmentation of 
functionality seems to be necessary to obtain a true alternative to the current “gold standard“, the 
autologous nerve graft. 
Possible augmentation of implant design 
The arrangement of guidance cues can influence an implant’s performance in terms of 
regeneration as shown, for example, by Clements et al. (2009). Thus a further improvement of my 
implant’s performance by adjustment of certain parameters is conceivable, e.g. by increasing the 
amount of fibers and their dispersion inside the implant. However, in the past decade there has 
been a variety of different design approaches for artificial nerve conduits with or without 
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incorporated physical/topographical guidance cues, and, to my knowledge, none of them was able 
to compete with the autologous nerve graft with respect to regeneration and functional recovery in 
gap sizes bigger than 1 cm. Apparently the incorporation of physical/topographical guidance cues 
has beneficial effect, but further augmentation, e.g. through implementation of biological 
signaling, seems necessary to obtain results equivalent to what can be achieved with autologous 
nerve grafts. 
There are several possibilities to equip an implant with biological signals that support axonal 
regeneration. An obvious way to achieve this is preseeding the conduit with appropriate cells 
before implantation. The positive effect of preseeded cells was shown in numerous studies with a 
variety of cell types (di Summa et al., 2010; Ding et al., 2010; Bozkurt et al., 2012; Allodi et al., 
2014; Beigi et al., 2014). As an example, by preseeding the Perimaix conduits with Schwann cells 
for repairing a 2 cm sciatic nerve lesion in rats Bozkurt et al. (2012) achieved regeneration that 
was almost as effective as when an autologous nerve graft was used. However, for the application 
in humans, which is the final therapeutic goal of all this research, preseeded conduits involve 
certain complications, as discussed earlier (Chapter I 3.4). Nevertheless, it is conceivable to 
mimic certain features those cells exhibit to support regeneration. 
One of those features is the secretion of ECM molecules. The ECM is equipped with a variety of 
molecular components that can be recognized by axonal receptors, e.g. integrins. Hence, a way to 
improve the performance of artificial implants is the incorporation of selected ECM components. 
In the present study, I used a rather simple approach to achieve an enhancement of the fibers 
guidance properties, namely by blending the PCL solution with collagen, a major ECM 
constituent. This was shown to have positive effects on Schwann cell migration and axonal 
regeneration in vitro (Schnell et al., 2007; Mey et al., 2012) and also led to slightly better 
performance in my in vitro experiments compared to pure PCL. More sophisticated methods 
involve chemical modification of materials by covalent binding of signaling peptides, e.g. an 
RGD sequence (arginine-glycine-aspartic acid), which cells can bind to via certain integrins (Koh 
et al., 2008; Bockelmann et al., 2011; Grafahrend et al., 2011). However, an advantage of 
covalent binding of signaling peptides to the guidance structure over mere blending of petides to 
the electrospinning solution could not be shown yet. 
Another beneficial feature cells exhibit to support regeneration is the release of growth factors. 
There is a variety of different growth factors known to support the regeneration of axons after 
PNI, e.g. NGF, GDNF, NT-3, CNTF etc. (Kokai et al., 2010, 2011; Allodi et al., 2011). 
Depending on the factor, the positive effect on regeneration is mediated through different 
mechanisms, for example the promotion of axonal outgrowth or neuronal survival (de Ruiter et 
al., 2009). Thus, by the combination of different growth factors, synergistic effects are to be 
expected that could lead to better support than the application of only a single type of growth 
factor (Madduri et al., 2010a). However more comprehensive analysis of the dose-dependency of 
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different factors and their possible interactions are desirable to choose the best combination of 
growth factors for an artificial nerve conduit. Possibilities for the incorporation of growth factors 
into artificial conduits have already been presented in a number of studies. Usually systems for 
the sustained delivery of factors over a longer period of time are preferred. This can be achieved 
by encapsulating the factors into slowly degradable materials, e.g. PCL or cross-linked gelatin 
(Xu et al., 2003; Moore et al., 2006; Chang, 2009; Valmikinathan et al., 2009; Solorio and 
Zwolinski, 2010; Kokai et al., 2011; Liu et al., 2011). 
Conclusion 
As shown by the experiments presented in this thesis, I successfully designed and manufactured a 
cell-free artificial nerve conduit for the support of peripheral nerve regeneration. The new design 
with the incorporated fiber/gel scaffold represents an improvement over a hollow collagen 
conduit. As the performance of my implant design with respect to the support of regeneration and 
functional recovery is generally on a comparable level with other designs presented so far, further 
effort in advancing the design for the use in humans is justified. To reach this goal I suggest the 
following steps to be taken.  
First of all, the physical structure of the internal scaffold should be optimized. The distribution of 
fibers inside the implants, used in the present study, was not homogenous. The fibers were mainly 
localized in the center of the scaffold in an area of approximately 1 mm width and 0.5 mm heights 
(when looking at a cross section). Here, one should strive for an adjustment of the procedure for 
fiber embedding and incorporation into the tube to obtain a more homogenous distribution of 
fibers throughout the whole cross section of the conduit. In my opinion a moderate increase in 
fiber density would also be favorable. This might prove beneficial for regeneration, while 
detrimental effects are not to be expected. At least I conclude this from comparisons with other 
studies were the process for manufacturing of the implants suggests a final fiber density that was 
higher than in the case presented here, e.g. (Jha et al., 2011). 
Secondly, biological signaling should be implemented into the conduit. To obtain the best 
possible results, I suggest to use a combination of functionalizing the fibers through modification 
of their surface with ECM molecules, as suggested by (Grafahrend et al., 2011), and the 
incorporation of a release system for growth factors. For this purpose, the use of microspheres 
encapsulating the growth factors seems reasonable, since they are already widely used in this 
context and can be incorporated into the conduit wall (Kokai et al., 2010). Additionally I suggest 
the use of cocktail of different growth factor to make use of synergistic effects. However ideal 
combinations and concentrations remain to be determined. 
Finally, before testing the optimized implants in humans, a second animal study in vivo, using the 
optimized implants, would be desirable. In this case, I suggest to choose a more challenging gap 
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size to be repaired. This way one should obtain more distinct differences between experimental 
groups, which eases the evaluation of the implants performance. However this requires a bigger 
animal model for example, e.g. Beagle dogs (Wang et al., 2005; Ding et al., 2010; Huang et al., 
2013). Also, in contrast to the present study, the assessment of functional recovery should be 
expanded to sensory function to give a more detailed insight into different aspects of regeneration. 
A successful completion of the suggested measures would, in my opinion, justify the start of 
clinical trials in humans. 
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